JPH0129167B2 - - Google Patents
Info
- Publication number
- JPH0129167B2 JPH0129167B2 JP58171064A JP17106483A JPH0129167B2 JP H0129167 B2 JPH0129167 B2 JP H0129167B2 JP 58171064 A JP58171064 A JP 58171064A JP 17106483 A JP17106483 A JP 17106483A JP H0129167 B2 JPH0129167 B2 JP H0129167B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- hemorrhage
- retinal
- animals
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000011282 treatment Methods 0.000 claims description 65
- 208000031969 Eye Hemorrhage Diseases 0.000 claims description 46
- 238000005345 coagulation Methods 0.000 claims description 43
- 230000015271 coagulation Effects 0.000 claims description 43
- 230000002207 retinal effect Effects 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 27
- 238000002347 injection Methods 0.000 claims description 15
- 239000007924 injection Substances 0.000 claims description 15
- 230000006378 damage Effects 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 6
- 239000003223 protective agent Substances 0.000 claims description 5
- 206010010356 Congenital anomaly Diseases 0.000 claims description 4
- 239000008024 pharmaceutical diluent Substances 0.000 claims description 4
- 208000032578 Inherited retinal disease Diseases 0.000 claims description 3
- 208000032430 Retinal dystrophy Diseases 0.000 claims description 3
- 201000006321 fundus dystrophy Diseases 0.000 claims description 3
- 208000017532 inherited retinal dystrophy Diseases 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- BNICBIMYAXBRQY-UHFFFAOYSA-N 1-hydroxypiperidine;hydrochloride Chemical compound [Cl-].O[NH+]1CCCCC1 BNICBIMYAXBRQY-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 description 144
- 229940079593 drug Drugs 0.000 description 136
- 241001465754 Metazoa Species 0.000 description 80
- 210000001508 eye Anatomy 0.000 description 62
- 208000032843 Hemorrhage Diseases 0.000 description 61
- 230000004304 visual acuity Effects 0.000 description 44
- 210000001525 retina Anatomy 0.000 description 26
- 238000010521 absorption reaction Methods 0.000 description 22
- 241000283973 Oryctolagus cuniculus Species 0.000 description 21
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 21
- 208000034158 bleeding Diseases 0.000 description 21
- 239000001301 oxygen Substances 0.000 description 21
- 229910052760 oxygen Inorganic materials 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 20
- 231100000319 bleeding Toxicity 0.000 description 19
- 230000000740 bleeding effect Effects 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000001225 therapeutic effect Effects 0.000 description 15
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 14
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 230000004044 response Effects 0.000 description 14
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 12
- 229960002897 heparin Drugs 0.000 description 12
- 229920000669 heparin Polymers 0.000 description 12
- 206010030113 Oedema Diseases 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 108010023197 Streptokinase Proteins 0.000 description 9
- 230000002008 hemorrhagic effect Effects 0.000 description 9
- 230000001953 sensory effect Effects 0.000 description 9
- 208000007536 Thrombosis Diseases 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 210000001957 retinal vein Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 206010039729 Scotoma Diseases 0.000 description 7
- 229910052786 argon Inorganic materials 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000000004 hemodynamic effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 230000004243 retinal function Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 208000034698 Vitreous haemorrhage Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000003969 polarography Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940087410 dexasone Drugs 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 230000003480 fibrinolytic effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000700112 Chinchilla Species 0.000 description 2
- 241000700114 Chinchillidae Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010088842 Fibrinolysin Proteins 0.000 description 2
- 206010058490 Hyperoxia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010038848 Retinal detachment Diseases 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 206010047115 Vasculitis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- QGNBTYAQAPLTMX-UHFFFAOYSA-L calcium dobesilate Chemical compound [Ca+2].OC1=CC=C(O)C(S([O-])(=O)=O)=C1.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 QGNBTYAQAPLTMX-UHFFFAOYSA-L 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000004424 eye movement Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229940001501 fibrinolysin Drugs 0.000 description 2
- -1 free radical lipid Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000000222 hyperoxic effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 238000002610 neuroimaging Methods 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000002577 ophthalmoscopy Methods 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000004264 retinal detachment Effects 0.000 description 2
- 201000007714 retinoschisis Diseases 0.000 description 2
- 210000003786 sclera Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 230000004382 visual function Effects 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 208000002691 Choroiditis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 201000010183 Papilledema Diseases 0.000 description 1
- BYPFEZZEUUWMEJ-UHFFFAOYSA-N Pentoxifylline Chemical compound O=C1N(CCCCC(=O)C)C(=O)N(C)C2=C1N(C)C=N2 BYPFEZZEUUWMEJ-UHFFFAOYSA-N 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 208000003971 Posterior uveitis Diseases 0.000 description 1
- 208000007135 Retinal Neovascularization Diseases 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 206010038886 Retinal oedema Diseases 0.000 description 1
- 206010038908 Retinal vein thrombosis Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- CMHKGULXIWIGBU-UHFFFAOYSA-N [Fe].[Pt] Chemical compound [Fe].[Pt] CMHKGULXIWIGBU-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 244000245420 ail Species 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000001309 degenerative myopia Diseases 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- JPGDYIGSCHWQCC-UHFFFAOYSA-N emoxypine Chemical compound CCC1=NC(C)=CC=C1O JPGDYIGSCHWQCC-UHFFFAOYSA-N 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 108010073651 fibrinmonomer Proteins 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 238000013534 fluorescein angiography Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 201000006408 generalized atherosclerosis Diseases 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000009540 indirect ophthalmoscopy Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 108010065073 lidase Proteins 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000004315 low visual acuity Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004342 moderate myopia Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003565 oculomotor Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000004515 progressive myopia Effects 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 229950008754 pyricarbate Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 201000011195 retinal edema Diseases 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000005336 safety glass Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 230000002666 vasoprotective effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 201000010371 vitreoretinal dystrophy Diseases 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Description
æ¬çºæã¯äžè¬çã«å»åŠã®åéã«é¢ãããã詳ã
ãã¯æ°èŠãªå»è¬åãå³ã¡ãçŒå åºè¡ãè¿èŠæ§è絡
網èãžã¹ãããã€ãŒãå 倩æ§ç¶²èãžã¹ãããã€
ãŒã網èç«å·ã®æ²»ççšåã³ã¬ãŒã¶ãŒååºã«ããã
æå·é²æ¢çšç¶²èä¿è·å€ãã«é¢ããã åŸæ¥åºç¯ãªåçºæ§åºè¡ã®åžåé床ãäžæããã
ãã®æ°å€ãã®è¬åãäŸãã°ãã€ããªããªãžã³ããŠ
ããããŒãŒãã¹ãã¬ãããããŒãŒããžã·ãã³ïŒãš
ã¿ã ã»ã¬ãŒãïŒãããã·ãŠãŒã ãªã©ãç¥ãããŠã
ãã åŸæ¥ãçŒç§ã®å®è·µã«ãããŠéåžžçšããããŠãã
æåºè¡å€ã¯ãçŒã®åŸ®å°åŸªç°ãå®å®åãããçŽç²ãª
è管æ é€è¡æïŒããã·ãŠãŒã ïŒãæãã¯æ¯çŽ°ç®¡åº
è¡ã®æ¥æ§çç¶ã«æçšãªæ¢è¡äœçšïŒãžã·ãã³ïŒãæ
ãã¯ç¶²èã®åŸâåºè¡å€åã«ãããŠé Œãã«ãããè¡
液ã®ã¬ãªããžãŒç¹æ§ã«åãŒãåºæå¹æïŒãã¬ã³ã¿
ã«ïŒãæãã¯ç¹å¥ã®è¡æ 厩å£å¹æïŒã¹ãã¬ããã
ã«ãŒãŒããããªã³ïŒã®ããããããããããã ããããªãããçŸåšç¥ãããŠããè¬å€ã®ããã
ããå€éäœçšãå³ã¡ã第ïŒã«ç®ã®åŸ®å°è管æ§é
ïŒè管å£ã®èæ§é ïŒãå®å®åããã第ïŒã«è¡æ¶²ã®
æååºåã³ãã€ããªã³æº¶è§£ç¹æ§ã«åœ±é¿ãåãŒãã
第ïŒã«åæã«å åºæã䌎ããæãã¯ç¹ã«äŒŽã€ãŠæ¬¡
第ã«å¢å€§ããè¿ éãªããªãŒã©ãžã«ã«èè³ªé žåãã
çããç Žå£éçšã劚害ããäœçšãèŠããã«åºè¡ã«
䌎ãç çåŠçå€åã®å šé åãå å«ããäœçšããæ
ãããã®ã§ã¯ãªãã æ¬çºæã®ç®çã¯ãäœãæ¯æ§ãåã³å€æ¹åæåºè¡
äœçšãå³ã¡ãèæ§é ã®å®å®åãåºè¡ãã®ä»ã®ç æ
ã䌎ãæ¿ããããªãŒã©ãžã«ã«é žåããã®èæ§é ã®
ä¿è·ãè¡æ¶²ã圢æããæåã®åé¢ã網èã«ããã
æ£åžžãªé žçŽ å©çšã®å埩ãåã³æ¯çŽ°ç®¡ééæ§ã®æž
å°ãã瀺ãæ°èŠãªå»è¬ãæäŸããããšã§ããã æ¬çºæã®å»è¬ã¯ãæç®ã«ä»¥åèšèŒãããŠããªã
æ°èŠãªçµæç©ã§ãããæ¬çºæã®çŒå åºè¡ãè¿èŠæ§
è絡網èåã³å 倩æ§ãžã¹ãããã€ãŒã網èç«å·ã®
æ²»ççšåã³ã¬ãŒã¶ãŒååºã«ãããæå·é²æ¢çšç¶²è
ä¿è·å€ã¯æŽ»æ§ç©è³ªåã³è¬åŠççšéå€ãããªããã
ã®æŽ»æ§ç©è³ªã¯æ¬¡åŒãæããïŒâãšãã«âïŒâã¡ã
ã«âïŒâããããã·ãããªãžã³å¡©é žå¡©ã§ããïŒ å¥œãŸããã¯ãæ¬çºæã®å»è¬ã¯ïŒééïŒ ã®æŽ»æ§ç©
質ãå«ã泚å°æ¶²åã³ç¹æ»Žå€çšã®æº¶æ¶²ã®åœ¢æ ã§çšã
ãããã 泚å°æº¶æ¶²çšã®å¥œãŸããè¬åŠççšéå€ã¯èžçæ°Žã§
ããã æ¬çºæã®å»è¬ã¯ã䟿å®äžãšã¢ãã·ãã³ãšåŒã°ã
ããã次ã®ç æ ã®æ²»ççšéã«é©ãããã®ã§ããã ïŒ äžå¿è絡網èãžã¹ãããã€ãŒã®ä¹Ÿç¥æïŒç©æ¥µ
çã«èŠåã«åœ±é¿ãåãŒãïŒã ïŒ äžå¿è絡網èãžã¹ãããã€ãŒã®æ»²åºâåºè¡æ
ïŒåºè¡ã®éšååžåãæèŠäžç®å¥é¢ã®é¢ç©æžå°ã
èŠåã®æ¹è¯ïŒã ïŒ åŸâè¡æ 網èåºè¡åã³äžå¿çŒåºã«ãããè質
æ²ç©ïŒåºè¡é åã®åžåãè質æ²çž®ã®åçž®ãèŠå
ã®æ¹è¯ïŒãè管厩å£ã«åŒãç¶ã1.5ã±æ以äžã®äž
å¿ç¶²èéèåã³ãã®æ¯èã«ãããè¡æ å å«ã®äº
æ¥æ§æ ïŒ è¿èŠæ§è絡網èãžã¹ãããã€ãŒïŒ(a)也ç¥æã
(b)åºè¡æã(c)ããã¯ã¹ïŒFuxâ²sïŒç¹ïŒåºè¡ã®é
åã®åžåãèŠåã®æ¹è¯ïŒã ïŒ ç³å°¿ç é¢é£ä»¥å€ã®åçš®è絡ç å ãçºç ã®æŽå²
ãæããçŒçåºè¡ïŒçŒçåºè¡ã®éšååžåãèŠå
ã®æ¹è¯ïŒã ïŒ ç¶²èã®æ¥å ã«ããççãã¬ãŒã¶ãŒè£ 眮æäœã«
䌎ã網èç«å·ïŒåºè¡é åã®åžåãåºè¡åã³æ»²åº
掻æ§ã®æžå°ãæç¹ã®æžå°ãèŠåã®æ¹è¯ïŒã ïŒ äžå¿å£æ¿â網èã¢ããªãããã€ãŒã ïŒ ç¡åäœç¶²èãžã¹ãããã€ãŒã ïŒ ã¬ãŒã¶ãŒååºã«ãããæå·ã®äºé²ã æ¬çºæã®è¬åã¯ãã¹ãã¬ã¹ãæ¿ããå ãé žçŽ é
å°çãçŒçå åºè¡ã«æããã網èã«æçãªäœçšã
ãã網èä¿è·å€ã§ãããããã¯ã網èé žçŽ ã®æ£åžž
ãªå©çšãå埩ããããšã網èãã®ä»ã®çµç¹å ã®ç°
ç¶ãã¯ã¬ãªããé¡ã®å«éãå¢å€§ãããããšãæ¯çŽ°
管ééæ§ãæžå°ãããããšãè¡å°æ¿åé¢ãèªçºã
ãããšãè¡æ¶²ç²åºŠãäœäžãããããšããã€ããªã³
ã¢ãããŒâãã€ããªã³ããªããŒè»¢æã®é床ãé ã
ããããšãããã³ãã³åœ¢æãé»æ¢ããããšãè¡æ¶²
ã®ãã€ããªã³æº¶è§£ç¹æ§ãé«ããããšãªã©ã®èœåã
æããããã«ããçŒå åºè¡åžåã«å¯äžããããšã
ã§ãããã®ã§ãããæ¬çºæã®ç¶²èä¿è·å€ã«é¢ãå
ç©åã³ããã«ã€ããŠèšåºããŒã¹ã§ç 究ãè¡ã€ãã ããäžã€ã®ç 究ã§ã¯ãçŒå åºè¡åžåã®å¹çã«é¢
ããŠæ¬çºæã®è¬åãããããµãœã³ãšçµåãããã
ããªã³ãšæ¯èŒããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¢ã«ãŽã³ã¬ãŒã¶ãŒãŠ
ããããçšããŠèªçºãããååºç«å·ã¯ããŒã åºå
200ã400ïœïŒ·ããµã€ãº50ã100ãã¯ãã³ãç §å°æ
é0.1ã0.2sãçšããŠèŠç¥çµã®å¹³åç€ç¶çµç¹ã®äžã«
äœããããæ¬çºæã®è¬åã®æ²»çå¹æããããªã³ãš
ãããµãœã³ã®çµåããã®ãããšå¯Ÿæ¯ããç 究ã¯ã
åã ïŒå¹ã®äºã€ã®çŸ€ïŒå矀10çŒïŒã«åãããã
2.5ãïŒKgã®äœéã®ãã³ãã©ç³»åã®10å¹ã®ãŠãµã®
ã«ã€ããŠè¡ãããã æ²»çã¯çŒåºã«ãããåºè¡ã®éå§åŸçŽã¡ã«éå§ã
ãããæ¬çºæã®è¬åã¯ãïŒïŒ 溶液0.5mlã®æäžé
ã§ãã€ãŠçŒçåŸæ¹ããæ¯æ¥ïŒåã®æäžã§15æ¥éå°
å ¥ãããããããªã³ãšãããµãœã³ïŒïŒæ³šå°åšäž
750åäœã®ãããªã³ã20mgã®ãããµãœã³ïŒã¯ã15
æ¥éã«äºã€ãŠæ¯æ¥äžåçŒçåŸæ¹ãã泚å°ãããã åºè¡éå§åŸïŒæ¥åŸã«ãæ¬çºæã®è¬åã§æ²»çãã
ãåç©ã«ãããŠãåºè¡åžåãçžåœèŠãããã®ã«å¯Ÿ
ãããããªã³åã³ãããµãœã³ãäžããããåç©çŸ€
ã«ãããŠã¯ãçŒåºåºè¡ã®çšåºŠã¯å®è³ªçã«å€åããª
ããŸãã§ãã€ãã 14æ¥ç®ãŸã§ã«ãæ¬çºæã®è¬åã§æ²»çãããåç©
ã¯å®å šãªåºè¡ã®åžåã瀺ããã®ã«å¯Ÿãããããªã³
ãšãããµãœã³ã®çµåãããåããåç©ã¯åžå掻æ§
ã¯ç€ºãããäŸç¶ãšããŠåºç¯ãªåºè¡ã瀺ããå®å šã«
æ²»çããããã«ã¯25ã30æ¥éããã€ãã åŸã€ãŠãæ¬çºæã®è¬åã¯ããããªã³ãšãããµãœ
ã³ã®çµåãããšå¯Ÿæ¯ããŠçŒå åºè¡ã®åžåã®é床ã
äžæããããšãã§ãããšçµè«ããããšãã§ããã æŽã«åãå¥ã®ç 究ã§ã¯ãçŒå åºè¡åžåã®å¹çã«
é¢ããŠãæ¬çºæã®è¬åããžã·ãã³ãšæ¯èŒããã ãŠãµã®ã®çŒå åºè¡ã¯ãã¬ãŒã¶ãŒãŠããããçšã
ãŠèªçºããããååºç«å·ã¯ããŒã åºå200ã400ïœ
ããµã€ãº50ã100ãã¯ãã³ãç §å°æé0.1ã0.2s
ãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«äœããããæ¬
çºæã®è¬åã®æ²»çå¹æããžã·ãã³ã®ãããšå¯Ÿæ¯ã
ãç 究ã¯ãåã ïŒå¹ã®ïŒçŸ€ïŒå矀10çŒïŒã«åãã
ãã2.5ãïŒKgã®ãã³ãã©ç³»åã®10å¹ã®ãŠãµã®ã«
ã€ããŠè¡ãããã æ²»çã¯çŒåºåºè¡éå§åŸçŽã¡ã«éå§ããããæ¬çº
æã®è¬åã¯ãïŒïŒ 溶液0.5mlã®æäžéã§çŒçåŸæ¹
ããæ¯æ¥ïŒå15æ¥éã«äºã€ãŠæäžãããããžã·ã
ã³ã¯çŒçåŸæ¹ãã12.5ïŒ æº¶æ¶²0.5mlã®æäžéã§æ¯
æ¥ïŒå15æ¥éã«äºã€ãŠæ³šå°ãããã åºè¡éå§åŸïŒæ¥åŸã«ãæ¬çºæã®è¬åã§æ²»çãã
ãåç©ã«ãããŠã¯ãåºè¡åžåãé¡èã§ãããååº
ç«å·ã®è¿ãã®æµ®è «ã¯ãããŸã€ãã®ã«å¯Ÿãããžã·ã
ã³ãäžããããåç©çŸ€ã«ãããŠã¯ãçŒåºåºè¡ã®çš
床ã¯åºè¡éå§åŸïŒæ¥ã«èŠããããã®ãšå®è³ªäžåäž
ã®ç¶æ ã«ãšã©ãŸã€ãŠããã 14æ¥ç®ãŸã§ã«ã¯ãæ¬çºæã®è¬åã§æ²»çãããå
ç©ã¯å®å šãªåºè¡ã®åžåã瀺ããã®ã«å¯Ÿãããžã·ã
ã³ãåããåç©ã¯äŸç¶ãšããŠåºç¯ãªåºè¡ã®èšŒæ ã
瀺ããå®å šãªæ²»çã«ã¯25ã30æ¥éããã€ãã åŸã€ãŠãæ¬çºæã®è¬åã¯ããžã·ãã³ã«æ¯ã¹ãŠçŒ
å ã¬ãŒã¶ãŒâèªçºåºè¡ã®åžåã®é床ãèããå¢å€§
ããããšãã§ãããšçµè«ä»ããããšãã§ããã æŽã«åãå¥ã®ç 究ã§ã¯ãçŒå åºè¡åžåã®å¹çã«
é¢ããŠãæ¬çºæã®è¬åãšã¹ãã¬ãããã«ãŒãŒã察
æ¯ããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¬ãŒã¶ãŒãŠãããã
çšããŠèªçºããããååºç«å·ã¯ããŒã åºå200ã
400ïœïŒ·ããµã€ãº50ã100ãã¯ãã³ãç §å°æé0.1
ã0.2sãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«äœãã
ããæ¬çºæã®è¬åã®æ²»çå¹çãã¹ãã¬ãããã«ãŒ
ãŒã®ãããšå¯Ÿæ¯ããç 究ã¯ãåã ïŒå¹ã®ïŒçŸ€ïŒå
矀10çŒïŒã«åããããïŒãïŒKgã®ãã³ãã©ç³»åã®
10å¹ã®ãŠãµã®ã«ã€ããŠè¡ãããã æ²»çã¯å®éšåºè¡ã®éå§åŸçŽã¡ã«éå§ããããæ¬
çºæã®è¬åã¯ïŒïŒ 溶液0.5mlã®æäžéã§çŒçåŸæ¹
ããæ¯æ¥ïŒåã®æäžã§15æ¥éè¡ããããã¹ãã¬ã
ããã«ãŒãŒã¯çŒçåŸæ¹ããåºè¡éå§ãã0.5mlã®
æäžéã§ïŒåïŒæ¥æ¯ã«ïŒïŒmlåœã10000åäœïŒæ³š
å°ãããã åºè¡éå§åŸïŒæ¥ç®ã«æ¬çºæã®è¬åã§æ²»çããã
åç©ã«ãããŠåºè¡åžåãçžåœã«èŠãããã®ã«å¯Ÿ
ããã¹ãã¬ãããã«ãŒãŒãäžããããåç©çŸ€ã«ã
ããŠã¯åºè¡ã®çšåºŠã¯å®è³ªçã«æªå€åã®ãŸãã«ãšã©
ãŸã€ããããããªãããã¹ãã¬ãããã«ãŒãŒãäž
ããããåç©ã¯ãåºç¯ãªæµ®è «åã³ãŸã¶ãåã³çµè
ãåãçºèµ€ã®åœ¢æ ããšãæ確ãªæè¬ã«å¯Ÿããã¢ã¬
ã«ã®ãŒåå¿ã瀺ããããšãææãããã¹ãã§ã
ãã 14æ¥ç®ãŸã§ã«ãæ¬çºæã®è¬åã§æ²»çãããåç©
ã¯çŒåºåºè¡ã®å®å šãªåžåã瀺ãããåäžææã«ã¹
ãã¬ãããã«ãŒãŒãäžããããåç©ã¯çžåœãªåºè¡
ã®äºæ ã®èšŒæ ã瀺ããŠããã åŸã€ãŠãæ¬çºæã®è¬åã¯ã¹ãã¬ãããã«ãŒãŒãš
察æ¯ããŠçŒå åºè¡ã®åžåé床ãäžæãããããšã
ã§ãããšçµè«ä»ããããšãã§ããã æ¬çºæã®è¬åã®æ²»çå¹æãåæ§ã«ã¬ãŒã¶ãŒèªçº
çŒå åºè¡ã®å¯Ÿç §åç©ç 究ã«ãããŠè©äŸ¡ããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¢ã«ãŽã³ã¬ãŒã¶ãŒãŠ
ããããçšããŠèªçºããããååºç«å·ã¯ããŒã åº
å200ã400ïœïŒ·ããµã€ãº50ã100ãã¯ãã³ãç §å°
æé0.1ã0.2sãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«
äœããããçŒåºã®åçãã¬ããããªããŠããã
ïŒRetinophot unitïŒãçšããŠæ®ã€ããåç©ã«ã¯æ¬
çºæã®è¬åãæ¯æ¥åäžæäžïŒïŒïŒ 溶液0.3ã0.5
mlïŒã§15æ¥éçµèäžæãã¯çŒçåŸæ¹ããæäžã
ãã網èé»äœå³ïŒERGïŒãåç©ã®é èäžã«ç®äž
çã«å°å ¥ããåºæºé»æ¥µïŒéŒè£œéïŒåã³çµã¿èŸŒã¿é»
極ãæããã¬ã³ãºãçšããŠã€ã³ã¯æžã蟌ã¿è³é 圱
ãŠãããäžã«èšé²ãããå åºæã¯0.3Jã®åºååã³
ç¶ç¶æé50ïœïœã®ãã©ãã·ãŠãã«ãã«ããäžãã
ãããåæèªçºå¿çããã³ã·ã€ã«åã³ãªã·ãã¹ã³
ãŒãããã³ã·ã€ã«ã¯ãªã·ãã¹ã³ãŒãã¹ã¯ãªãŒã³ã®
ããŒãäžã«èšé²ãããããã©ãã·ãŠåœãã®æå¹ãš
ãã«ã®ãŒæ¶è²»ã¯180Jã§ããã350ããªç§ïŒïœïœïŒ
ç¶ç¶ããã40å¹ïŒå³ã¡80çŒïŒã«ãããæ²»çã¯ãã¬
ãŒã¶ãŒèªçºçŒå åºè¡åŸçŽã¡ã«éå§ããããïŒçŸ€ã®
å¯Ÿç §åç©ã䜿çšããããå³ã¡ã第ïŒã®çŸ€ã¯ãã©ã·
ãŒãïŒåœè¬ïŒåŠæ¹ã®ãã®ïŒ10å¹ã20çŒïŒã§ããã
第ïŒã®çŸ€ã¯æè¬ãªãã®ãã®ã§ãã€ãïŒ20å¹ã40
çŒïŒã å¯Ÿç §åç©åã³ç 究åç©ã®äž¡è ã«ãããŠãã¬ãŒã¶
ãŒååºåŸçŽã¡ã«åã³ïŒæ¥åŸã«ååºçŒåºé åè¿èŸºã®
åã³ç¡åäœã«å»¶åšãã網èåšèŸºåã³ç¶²èã®åºè¡ã®
城åãèŠãããããã®æå·ã¯ãæ¬çºæã®è¬åãæ
è¬ãããåç©ã«ãããŠã¯ããã軜ããã®ã§ãã€
ããåºè¡éå§åŸïŒæ¥åŸã«ç 究矀äžã®åç©ã¯æµ®è «ã
å®å šã«ãããŸããé¡èãªåºè¡ã®åžåã瀺ããã察
ç §åç©ã«ãããŠã¯ãåºè¡ã®çšåºŠã¯å®è³ªçã«å€åã
ãã網èè¡æ¶²ã®ç¡åäœãžã®æµåºã䌎ããããåç©
ã«ãããŠã¯éšåççŒçåºè¡ã圢æãããåºè¡éå§
åŸ14æ¥ç®ãŸã§ã«ãç 究ã°ã«ãŒãäžã®åç©ã¯åºè¡ã®
å®å šãªåžåãããã®ã«å¯Ÿããå¯Ÿç §åç©ã«ãããŠã¯
ããåç©ã«ãããŠã¯ç¡åäœã«åœ±é¿ãåãŒãç¶ç¶ç
網èåºè¡åã³éšåççŒçåºè¡ã®èšŒæ ãååšããã
å¯Ÿç §åç©ã«ãããåºè¡ã®å®å šãªåžåã¯1.0ã1.5ã±
æéã®æéã«äºã€ãã ãã®ããã«ãæ¬çºæã®è¬åã¯ãçŒå åºè¡ã®æ²»ç
ã«ãããŠãæçšãªåŒ·åãªæ²»çäœçšãæãããã®ã§
ãããå¯Ÿç §ïŒæªæ²»çïŒããã³å®éšïŒæ¬çºæã®è¬å
ã§æ²»çïŒåç©çŸ€ã«ãããé»æ°ççåŠçè©Šéšãè¡ã€
ãŠåºè¡äžã®ç¶²èã®æ©èœç¶æ ã®è©äŸ¡ãè¡ã€ãã é»æ°ççåŠçç 究ïŒç¶²èé»äœå³ïŒããåŸããã
çµæã第ïŒå³åã³ç¬¬ïŒå³ã«å³ç€ºãããïœæ³¢ã®çžå¯Ÿ
çæ¯å¹ ã瞊軞ã«ãããããïŒç¬¬ïŒå³ïŒãïœæ³¢ã®ã
ãã瞊軞ã«ãããããïŒç¬¬ïŒå³ïŒãããããåæ
網èé»äœå³ä¿¡å·ã®ïŒ ã§ç€ºããåºè¡éå§åŸã®æéçµ
éã暪軞ïŒåç¹ã60åã次ãã§ïŒæ¥ééã§14æ¥
éïŒã«ããããããã第ïŒå³åã³ç¬¬ïŒå³ã«ãããŠ
ïŒã§ç€ºãããæ²ç·ã¯å¯Ÿç §çŸ€ããã®çµæã§ãããïŒ
ã§ç€ºãããæ²ç·ã¯ç 究矀ïŒè¬åæ²»çïŒã®ãã®ã§ã
ãã é»æ°çååŠçè©Šéšã®çµæã§ã¯ãæ¬çºæã®è¬åã§
æ²»çãããªãåç©ïŒç¬¬ïŒå³åã³ç¬¬ïŒå³ã®æ²ç·ïŒïŒ
ã«ãããŠã¯ãERGä¿¡å·ã¯éãæå¶ãããããšã
瀺ããããè¬åæ²»çãããåç©ïŒç¬¬ïŒå³åã³ç¬¬ïŒ
å³ã®æ²ç·ïŒïŒã«ãããïœåã³ïœã®ERGæ²ç·ã¯10
ã15æ¥ç®ã«æ£åžžã«æ»ã€ãã®ã«å¯Ÿããéæè¬åç©ã«
ãããïœåã³ïœã®ERGæ²ç·ã¯åäžæç¹ã«ãããŠ
ããããå¯Ÿç §å€ã®37ã42ïŒ ã§ãã€ããéæè¬åç©
ã«ãããERGã¯æ²»çåç©ã®ããã«æ¯èŒããŠæ£åžž
ã«æ»ãã®ã«çžåœã«é·ãæéãèŠãã網èé»æ°ç掻
æ§ã®å®å šãªå埩ã¯1.5ãïŒã±æããã€ãŠè¡ãããã æªåŠçåç©ã«ãããåæèªçºå¿çããã³ã·ã€ã«
ïŒR2RRPã第ïŒå³ïŒ¡ïŒïŒïŒïŒãåçžåœã«å€åãã
ãã®æ¯å¹ ã¯åºè¡éå§åŸïŒæ¥ç®ãŸã§ã«æ£åžžå€ã®60ïŒ
ã«ãã¡ãã®ã«å¯Ÿããåæç¹ã«ãããŠè¬åã§æ²»çã
ãããŠãµã®ã«ãããR2RRPå€ã¯æ¢ã«åæã®æ°Žæº
ã«å°éããïŒç¬¬ïŒå³ïŒ¡ïŒïŒïŒïŒïŒãïŒæ¥ç®ãŸã§ã®ãª
ã·ãã¹ã³ãŒãããã³ã·ã€ã«å€ã¯ãåŠçåç©ã«ãã
ãŠãã®å¯Ÿç §æ°Žæºã«éæããã®ã«å¯ŸãïŒç¬¬ïŒå³ïŒ¢ïŒ
ïŒïŒïŒïŒãéæè¬åç©ã«ããããã®ããã³ã·ã€ã«ã®
çžå¯Ÿçæ¯å¹ ïŒç¬¬ïŒå³ïŒ¢ïŒïŒïŒïŒã¯å¯Ÿç §å€ã®60ã70
ïŒ ã§ãã€ãã第ïŒå³ïŒ¡ïŒïŒ¢ã¯èšé²ãããå åºæã
å³ç€ºãããã®ã§ããã åŸã€ãŠãæ¬çºæã®è¬åã¯ã網èæ©èœåã³çäœã
ãã³ã·ã€ã«ã«åœ±é¿ãåãŒãçŒå åºè¡é¢é£é害ã®åº
çŸãé²æ¢ããããšãã§ãããã®ã§ããã æ¬çºæã®è¬åã¯ãåçºæ§çŒå åºè¡ã®åžåãä¿é²
ããäœçšãæãããšå ±ã«æ°ãã«åŒãèµ·ããããåº
è¡ã«å¯ŸããçŒå æ§é ã«ä¿è·çå¹æãåãŒããã®ã§
ããã åŸâæäœæéåã³ã¬ãŒã¶ãŒååºåŸã«äœ¿çšããã
æ¬çºæã®è¬åã®ä¿è·ç¹æ§ãåãåç©å®éšã§è©äŸ¡ã
ããã¬ãŒã¶ãŒååºã¯ã¢ã«ãŽã³åã³ã¯ãªããã³ã¬ãŒ
ã¶ãŒãŠããããçšããŠè¡ããããååºç«å·ã¯ããŒ
ã åºå400ïœïŒ·ããµã€ãº200ãã¯ãã³ãç §å°æé
0.1ã0.2ïœïœãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«
äœããããçŒåºã®åçã¯ã¬ãããªããŠããããçš
ããŠæ®ããããå¯Ÿç §è©Šéšåã³ç 究詊éšã«çšããã
ãåç©ã®ç·æ°ã¯60å¹ïŒ120çŒãå矀60çŒïŒã§ãã€
ãã åç©ãäºé²ã¹ã±ãžãŠãŒã«ïŒïŒæ¥åã³æ¬¡ãã§ã¬ãŒ
ã¶ãŒååºåïŒæéïŒã«ãããæ¬çºæã®è¬åã«ãã
æ²»çã¯ïŒïŒ 溶液0.5mlã®æäžéã§æ¯æ¥ïŒåã10ã
15æ¥éæäžã§è¡ãªã€ãã å¯Ÿç §ïŒæªæ²»çïŒåã³è©ŠéšïŒæ²»çïŒåç©ã®ããã
ã«ãããŠãã¬ãŒã¶ãŒååºåŸçŽã¡ã«åã³ïŒæ¥åŸã«å
åºãããçŒåºé åã®è¿èŸºã«ãããŠæµ®è «ã®åŸŽåãã
ããããã¯äºé²æ²»çãåããªãã€ãåç©ã«ãããŠ
ããé¡èã§ãã€ããã¬ãŒã¶ãŒååºåã«æ¬çºæã®è¬
åã§åŠçãããåç©ã«ãããŠã¯ãçŒåºåºè¡ã®èªçº
ã¯å°é£ã§ãã€ããååºåŸïŒæ¥ç®ã«å¯Ÿç §çŸ€æãã¯è©Š
éšçŸ€ã®åç©ã®ãããã«ãããŠãååºç«å·çè²ã®èšŒ
æ ã¯ãªãã€ãã ãã®åŸå šãŠã®å¯Ÿç §åç©ã«ã€ããŠè¡ãããæ€çŒé¡
æ€æ»ã®çµæãååºç«å·ã®åšãã®æµ®è «ã¯ååºåŸïŒæ¥
ç®ãŸã§ãããŸããååºç«å·çè²ã¯åŒç¶ããŠèµ·ãã€
ãããšãã¿ãšããããããã®æ€çŒé¡æ€æ»ã®ç¥èŠã
ãæ¬çºæã®è¬åã§æ²»çãããªãåç©ã«ããã網è
ãžã®ç±çæå·ã®åŸŽåã¯ã¬ãŒã¶ãŒååºåŸïŒãïŒæ¥åŸ
ã«èµ·ãããã®ãšæšå®ãããã æ¬çºæã®è¬åã®ã¬ãŒã¶ãŒååºã«ããã䜿çšã¯ã¬
ãŒã¶ãŒæ²»çã«äŒŽã網èã®å埩å€åãèããä¿é²ã
ããæ¬çºæã®è¬åã«ããäºé²æ²»çãåããåç©ã®
æ€çŒé¡è©Šéšã¯ååºç«å·ã®é åã«ãããæµ®è «ã®åŸŽå
ã¯ïŒæ¥ç®ãŸã§ã«å®å šã«ãããŸããæœåšçååºç«å·
çè²ã¯åæã«é²è¡ãã¯ãããããšã瀺ããããã®
æ€çŒé¡è©Šéšã®ç¥èŠã«ããã°ãæ¬çºæã®è¬åãåã
åãåç©ã«ãããŠã¯ã網èååºç«å·ã®çè²ã¯ã¬ãŒ
ã¶ãŒååºåŸå¯Ÿç §çŸ€ã«ãããïŒãïŒæ¥ç®ã«å¯ŸããŠã
ïŒæ¥ç®ãŸã§ã«å®äºãããšããçµè«ãå°ãããã å¯Ÿç §çŸ€ïŒæªæ²»çïŒåã³è©ŠéšçŸ€ïŒäºé²çã«æ²»çïŒ
ã®åç©ã«ãããé»æ°ççåŠçè©Šéšãè¡ã€ãŠãã¬ãŒ
ã¶ãŒååºã«ããã網èã®æ©èœç¶æ ãè©äŸ¡ãããé»
æ°ççåŠç 究ïŒERGïŒããåŸãããçµæã¯ç¬¬ïŒ
å³ã«ç€ºããïœåã³ïœæ³¢ã®çžå¯Ÿçæ¯å¹ ã¯çžŠè»žã«ãã€
ã¯ããã«ãã§ããããããŠããã暪軞ã¯åºè¡éå§
åŸã®çµéæéããããããããã®ã§ããïŒåç¹â
60åã次ãã§ïŒæ¥ééã§14æ¥éïŒã第ïŒå³ã«ãã
ãé»æ°ççåŠççµæã§ã¯ãäºé²åã³ããã«åŒç¶ã
è¬åæ²»çãè¡ãããŠããåç©ã«ãããŠïœåã³ïœæ³¢
ã¯10ã15æ¥ç®ãŸã§ã«æ£åžžã«æ»ã€ãããšã瀺ããã
åäžæéãŸã§ã«éæè¬åç©ã«ãããïœåã³ïœïŒïŒ©ïŒ
ERGæ³¢ã®æ¯å¹ ã¯å¯Ÿç §å€ã®å ãã«60ïŒ ã§ãã€ãã éâæè¬åç©ã«ãããERGã¯æ¬çºæã®è¬åã®
äºé²çåã³ããã«åŒç¶ãåŠæ¹ãåããŠããåç©ã®
ããã«å¯Ÿæ¯ããŠæ£åžžã«æ»ãã®ã«çžåœã«é·ãæéã
ããã€ãããšã匷調ãããã¹ãã§ãããå¯Ÿç §åç©
ïŒè¬åç¡æäžïŒã«ãããERGæ³¢ã®å®å šãªå埩ã¯1.5
ãïŒã±æã®æéã«äºã€ãŠçããã ãã®ããã«ãæ¬çºæã®è¬åã¯ãã¬ãŒã¶ãŒååºã«
ãããŠäºé²çäœçšã®åããããæ£åžžç¶²èæ©èœãä¿
åããã¬ãŒã¶ãŒååºåŸç¶²èã«ãããåçå€åãä¿
é²ãããã€ç¶²èåºè¡ãäºé²ããããšãã§ãããã®
ã§ããã æ¬çºæã®è¬åã®æ²»çå¹çãã¬ãŒã¶ãŒèªçºç¶²èç«
å·ã«ãããŠç 究ããã äžé£ã®å®éšãäœéïŒã3.5Kgã®ãã³ãã©ç³»åã®
20å¹ã®ãŠãµã®ã«ã€ããŠè¡ã€ããã¬ãŒã¶ãŒç«å·ã¯ã¢
ã«ãŽã³ã¬ãŒã¶ãŒãŠããããçšããŠèªçºãããçŒåº
ç«å·ã¯ããŒã åºå600ïœïŒ·ããµã€ãº500ÎŒãç §å°æ
é0.1ã0.2sãçšããŠåç©ã®èŠç¥çµå¹³åç€ç¶çµç¹ã®
äžã«äœã€ããåŒç¶ãç¶æ å€åã®èŠå¯ã¯éæ¥æ€çŒé¡
æ€æ»æ³åã³ã¬ããããªãåçãçšããŠè¡ã€ãã察
ç §åç©çŸ€ã¯ãè¬åãå šãåãåããªãã€ããç 究
矀ã®åç©ã¯ãæ¬çºæã®è¬åãïŒïŒ 溶液0.5mlã®æ
äžéãããªãæ²»çåŠæ¹ããåç©ã®ç®ã«ãããŠç¶²è
æå·ããããŠããïŒæ¥éã«äºã€ãŠçŒçåŸæ¹ããã®
泚å°ã«ããåãåã€ããå¯Ÿç §åã³ç 究åç©ã®ãã
ãã«ãããŠã網èç«å·ã®èªçºåŸçŽã¡ã«å®æœçŒåºé
åã«ãããŠæã ã«å°ããªåºè¡ã䌎ãæ確ãªæµ®è «ã®
城åãèŠããããç 究åç©ã«ãããŠã¯ãç«å·èªçº
åŸïŒæ¥ç®ã«åçã«æžå°ãã滲åºæŽ»æ§ã®èšŒæ ãèŠã
ããïŒãïŒæ¥ç®ãŸã§ã«ã¯å®å šã«ãããŸããçè²ã
ãå·è·¡ãç«å·ç®æã«ïŒãïŒæ¥ç®ãŸã§ã«åœ¢æãã
ãã å¯Ÿç §çŸ€ã®åç©ïŒæªæ²»çïŒã«ãããŠãïŒãïŒæ¥ç®
ã«è¡ãããæ€çŒé¡æ€æ»ã§ã¯æµ®è «åã³éå®ãããåº
è¡ã®åŸŽåãèŠããããïŒæ¥ç®ãŸã§ã«ã¯æã ã«æµ®è «
ã®æžå°ãèŠãããååºç«å·ã®åæã®éšåççè²åŸŽ
åã䌎ããã®ã§ãã€ããå¯Ÿç §åç©ïŒæªæ²»çïŒã«ã
ããååºç«å·ã®å®å šçè²ã¯å¹³åããŠ14æ¥ç®ãŸã§ã«
èµ·ã€ãã çµè«ãšããŠãæ¬çºæã®è¬åã¯ã¬ãŒã¶ãŒèªçºç¶²è
ç«å·ã®æ²»çã«ãããŠæçšãªåŒ·åãªæ²»çå€ãšããã
ãšãã§ããã ã¬ãŒã¶ãŒèªçºçŒå åºè¡ã®çäŸã«ãããŠè¡æµçŒç
éåæ³ãçšããŠçŒã®è¡è¡ååŠãç 究ããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¬ãŒã¶ãŒãŠãããã
çšããŠèªçºãããååºç«å·ã¯ããŒã åºå200ã400
ïœïŒ·ããµã€ãº50ã100ÎŒãç §å°æé0.1ã0.2ç§ãçš
ããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«äœã€ããçŒåºãã¬
ããããªããŠããããçšããŠåçæ®åœ±ãããåç©
ã¯ãæ¬çºæã®è¬åã®ïŒïŒ 溶液ïŒ50mlïŒã§åºè¡éå§
ã®æ¥ããå§ããŠæ¯æ¥äžåæ²»çã®å šæéïŒ15æ¥ïŒçŒ
çåŸæ¹ããæäžããŠæ²»çãããè¡æµçŒçéåã¯L.
A.ã«ãããã«ãœã³ïŒL.A.KatsnelsonïŒæ³ã«ãã
é»æ°è³é 圱æ®åœ±ãŠãããã«åãä»ããã¬ãªã°ã©ã
è£ çœ®ãçšããŠè¡ã€ããã¬ãªã°ã©ãå åã¯æ¬¡åŒãçš
ããŠèšç®ããã RqïŒïŒ¡ã»Ewã»1000ïŒEzã»ïŒ² ãåŒäžïŒ¡ã¯ãã«ã¹æ³¢æ¯å¹ ïŒmmïŒã Ewã¯èŒæ£ãã«ã¹ã§ããïŒãªãŒã ïŒã ã¯é»æ¥µæµæïŒã€ã³ããŒãã³ã¹ïŒïŒãªãŒã ïŒ ã§ããã Ezã¯èŒæ£ãã«ã¹ïŒmmïŒã§ãããã çµæïŒè¡šïŒïŒã®è©äŸ¡ã¯ãçŒå åºè¡ã¯éãæžå°ã
ãè¡æµçŒçéåæ¯å¹ ãçãããã®çµæãåºè¡éå§
åŸïŒæéçšã®æ©ãææã«ã¬ãªã°ã©ãå åRqã¯å¯Ÿ
ç §å€ã®50ïŒ ãŸã§äœäžããããšã瀺åããŠãããã
ã®è¡æµçŒçéåå³ã«ãããæžè¡°ã¯æ¯èŒçå®å®ãã
æ§è³ªãæããRqå€ã¯åºè¡éå§åŸ14æ¥ç®ã«ãäœç
ã®å€åã瀺ããªãããŠãµã®ã«ãããç®ã®è管路ã«
ãããè¡è¡ååŠã¯åºè¡éå§åŸïŒé±éã§éå§ããå
埩ãžã®ãã€ããããé²è·¯ãåããã®çµæ30æ¥çµé
åŸã«ã¬ãªã°ã©ãå åã¯å¯Ÿç §å€ã®56ïŒ ãŸã§ã«äžæã
ããè¡æµçŒçéåå³ã®å®å šãªæ£åžžåã¯åºè¡éå§åŸ
1.0ã1.5ã±æåŸã«éåžžèµ·ãããç 究çµæãè¡šïŒã«
ãŸãšããŠç€ºãã
ãã¯æ°èŠãªå»è¬åãå³ã¡ãçŒå åºè¡ãè¿èŠæ§è絡
網èãžã¹ãããã€ãŒãå 倩æ§ç¶²èãžã¹ãããã€
ãŒã網èç«å·ã®æ²»ççšåã³ã¬ãŒã¶ãŒååºã«ããã
æå·é²æ¢çšç¶²èä¿è·å€ãã«é¢ããã åŸæ¥åºç¯ãªåçºæ§åºè¡ã®åžåé床ãäžæããã
ãã®æ°å€ãã®è¬åãäŸãã°ãã€ããªããªãžã³ããŠ
ããããŒãŒãã¹ãã¬ãããããŒãŒããžã·ãã³ïŒãš
ã¿ã ã»ã¬ãŒãïŒãããã·ãŠãŒã ãªã©ãç¥ãããŠã
ãã åŸæ¥ãçŒç§ã®å®è·µã«ãããŠéåžžçšããããŠãã
æåºè¡å€ã¯ãçŒã®åŸ®å°åŸªç°ãå®å®åãããçŽç²ãª
è管æ é€è¡æïŒããã·ãŠãŒã ïŒãæãã¯æ¯çŽ°ç®¡åº
è¡ã®æ¥æ§çç¶ã«æçšãªæ¢è¡äœçšïŒãžã·ãã³ïŒãæ
ãã¯ç¶²èã®åŸâåºè¡å€åã«ãããŠé Œãã«ãããè¡
液ã®ã¬ãªããžãŒç¹æ§ã«åãŒãåºæå¹æïŒãã¬ã³ã¿
ã«ïŒãæãã¯ç¹å¥ã®è¡æ 厩å£å¹æïŒã¹ãã¬ããã
ã«ãŒãŒããããªã³ïŒã®ããããããããããã ããããªãããçŸåšç¥ãããŠããè¬å€ã®ããã
ããå€éäœçšãå³ã¡ã第ïŒã«ç®ã®åŸ®å°è管æ§é
ïŒè管å£ã®èæ§é ïŒãå®å®åããã第ïŒã«è¡æ¶²ã®
æååºåã³ãã€ããªã³æº¶è§£ç¹æ§ã«åœ±é¿ãåãŒãã
第ïŒã«åæã«å åºæã䌎ããæãã¯ç¹ã«äŒŽã€ãŠæ¬¡
第ã«å¢å€§ããè¿ éãªããªãŒã©ãžã«ã«èè³ªé žåãã
çããç Žå£éçšã劚害ããäœçšãèŠããã«åºè¡ã«
䌎ãç çåŠçå€åã®å šé åãå å«ããäœçšããæ
ãããã®ã§ã¯ãªãã æ¬çºæã®ç®çã¯ãäœãæ¯æ§ãåã³å€æ¹åæåºè¡
äœçšãå³ã¡ãèæ§é ã®å®å®åãåºè¡ãã®ä»ã®ç æ
ã䌎ãæ¿ããããªãŒã©ãžã«ã«é žåããã®èæ§é ã®
ä¿è·ãè¡æ¶²ã圢æããæåã®åé¢ã網èã«ããã
æ£åžžãªé žçŽ å©çšã®å埩ãåã³æ¯çŽ°ç®¡ééæ§ã®æž
å°ãã瀺ãæ°èŠãªå»è¬ãæäŸããããšã§ããã æ¬çºæã®å»è¬ã¯ãæç®ã«ä»¥åèšèŒãããŠããªã
æ°èŠãªçµæç©ã§ãããæ¬çºæã®çŒå åºè¡ãè¿èŠæ§
è絡網èåã³å 倩æ§ãžã¹ãããã€ãŒã網èç«å·ã®
æ²»ççšåã³ã¬ãŒã¶ãŒååºã«ãããæå·é²æ¢çšç¶²è
ä¿è·å€ã¯æŽ»æ§ç©è³ªåã³è¬åŠççšéå€ãããªããã
ã®æŽ»æ§ç©è³ªã¯æ¬¡åŒãæããïŒâãšãã«âïŒâã¡ã
ã«âïŒâããããã·ãããªãžã³å¡©é žå¡©ã§ããïŒ å¥œãŸããã¯ãæ¬çºæã®å»è¬ã¯ïŒééïŒ ã®æŽ»æ§ç©
質ãå«ã泚å°æ¶²åã³ç¹æ»Žå€çšã®æº¶æ¶²ã®åœ¢æ ã§çšã
ãããã 泚å°æº¶æ¶²çšã®å¥œãŸããè¬åŠççšéå€ã¯èžçæ°Žã§
ããã æ¬çºæã®å»è¬ã¯ã䟿å®äžãšã¢ãã·ãã³ãšåŒã°ã
ããã次ã®ç æ ã®æ²»ççšéã«é©ãããã®ã§ããã ïŒ äžå¿è絡網èãžã¹ãããã€ãŒã®ä¹Ÿç¥æïŒç©æ¥µ
çã«èŠåã«åœ±é¿ãåãŒãïŒã ïŒ äžå¿è絡網èãžã¹ãããã€ãŒã®æ»²åºâåºè¡æ
ïŒåºè¡ã®éšååžåãæèŠäžç®å¥é¢ã®é¢ç©æžå°ã
èŠåã®æ¹è¯ïŒã ïŒ åŸâè¡æ 網èåºè¡åã³äžå¿çŒåºã«ãããè質
æ²ç©ïŒåºè¡é åã®åžåãè質æ²çž®ã®åçž®ãèŠå
ã®æ¹è¯ïŒãè管厩å£ã«åŒãç¶ã1.5ã±æ以äžã®äž
å¿ç¶²èéèåã³ãã®æ¯èã«ãããè¡æ å å«ã®äº
æ¥æ§æ ïŒ è¿èŠæ§è絡網èãžã¹ãããã€ãŒïŒ(a)也ç¥æã
(b)åºè¡æã(c)ããã¯ã¹ïŒFuxâ²sïŒç¹ïŒåºè¡ã®é
åã®åžåãèŠåã®æ¹è¯ïŒã ïŒ ç³å°¿ç é¢é£ä»¥å€ã®åçš®è絡ç å ãçºç ã®æŽå²
ãæããçŒçåºè¡ïŒçŒçåºè¡ã®éšååžåãèŠå
ã®æ¹è¯ïŒã ïŒ ç¶²èã®æ¥å ã«ããççãã¬ãŒã¶ãŒè£ 眮æäœã«
䌎ã網èç«å·ïŒåºè¡é åã®åžåãåºè¡åã³æ»²åº
掻æ§ã®æžå°ãæç¹ã®æžå°ãèŠåã®æ¹è¯ïŒã ïŒ äžå¿å£æ¿â網èã¢ããªãããã€ãŒã ïŒ ç¡åäœç¶²èãžã¹ãããã€ãŒã ïŒ ã¬ãŒã¶ãŒååºã«ãããæå·ã®äºé²ã æ¬çºæã®è¬åã¯ãã¹ãã¬ã¹ãæ¿ããå ãé žçŽ é
å°çãçŒçå åºè¡ã«æããã網èã«æçãªäœçšã
ãã網èä¿è·å€ã§ãããããã¯ã網èé žçŽ ã®æ£åžž
ãªå©çšãå埩ããããšã網èãã®ä»ã®çµç¹å ã®ç°
ç¶ãã¯ã¬ãªããé¡ã®å«éãå¢å€§ãããããšãæ¯çŽ°
管ééæ§ãæžå°ãããããšãè¡å°æ¿åé¢ãèªçºã
ãããšãè¡æ¶²ç²åºŠãäœäžãããããšããã€ããªã³
ã¢ãããŒâãã€ããªã³ããªããŒè»¢æã®é床ãé ã
ããããšãããã³ãã³åœ¢æãé»æ¢ããããšãè¡æ¶²
ã®ãã€ããªã³æº¶è§£ç¹æ§ãé«ããããšãªã©ã®èœåã
æããããã«ããçŒå åºè¡åžåã«å¯äžããããšã
ã§ãããã®ã§ãããæ¬çºæã®ç¶²èä¿è·å€ã«é¢ãå
ç©åã³ããã«ã€ããŠèšåºããŒã¹ã§ç 究ãè¡ã€ãã ããäžã€ã®ç 究ã§ã¯ãçŒå åºè¡åžåã®å¹çã«é¢
ããŠæ¬çºæã®è¬åãããããµãœã³ãšçµåãããã
ããªã³ãšæ¯èŒããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¢ã«ãŽã³ã¬ãŒã¶ãŒãŠ
ããããçšããŠèªçºãããååºç«å·ã¯ããŒã åºå
200ã400ïœïŒ·ããµã€ãº50ã100ãã¯ãã³ãç §å°æ
é0.1ã0.2sãçšããŠèŠç¥çµã®å¹³åç€ç¶çµç¹ã®äžã«
äœããããæ¬çºæã®è¬åã®æ²»çå¹æããããªã³ãš
ãããµãœã³ã®çµåããã®ãããšå¯Ÿæ¯ããç 究ã¯ã
åã ïŒå¹ã®äºã€ã®çŸ€ïŒå矀10çŒïŒã«åãããã
2.5ãïŒKgã®äœéã®ãã³ãã©ç³»åã®10å¹ã®ãŠãµã®
ã«ã€ããŠè¡ãããã æ²»çã¯çŒåºã«ãããåºè¡ã®éå§åŸçŽã¡ã«éå§ã
ãããæ¬çºæã®è¬åã¯ãïŒïŒ 溶液0.5mlã®æäžé
ã§ãã€ãŠçŒçåŸæ¹ããæ¯æ¥ïŒåã®æäžã§15æ¥éå°
å ¥ãããããããªã³ãšãããµãœã³ïŒïŒæ³šå°åšäž
750åäœã®ãããªã³ã20mgã®ãããµãœã³ïŒã¯ã15
æ¥éã«äºã€ãŠæ¯æ¥äžåçŒçåŸæ¹ãã泚å°ãããã åºè¡éå§åŸïŒæ¥åŸã«ãæ¬çºæã®è¬åã§æ²»çãã
ãåç©ã«ãããŠãåºè¡åžåãçžåœèŠãããã®ã«å¯Ÿ
ãããããªã³åã³ãããµãœã³ãäžããããåç©çŸ€
ã«ãããŠã¯ãçŒåºåºè¡ã®çšåºŠã¯å®è³ªçã«å€åããª
ããŸãã§ãã€ãã 14æ¥ç®ãŸã§ã«ãæ¬çºæã®è¬åã§æ²»çãããåç©
ã¯å®å šãªåºè¡ã®åžåã瀺ããã®ã«å¯Ÿãããããªã³
ãšãããµãœã³ã®çµåãããåããåç©ã¯åžå掻æ§
ã¯ç€ºãããäŸç¶ãšããŠåºç¯ãªåºè¡ã瀺ããå®å šã«
æ²»çããããã«ã¯25ã30æ¥éããã€ãã åŸã€ãŠãæ¬çºæã®è¬åã¯ããããªã³ãšãããµãœ
ã³ã®çµåãããšå¯Ÿæ¯ããŠçŒå åºè¡ã®åžåã®é床ã
äžæããããšãã§ãããšçµè«ããããšãã§ããã æŽã«åãå¥ã®ç 究ã§ã¯ãçŒå åºè¡åžåã®å¹çã«
é¢ããŠãæ¬çºæã®è¬åããžã·ãã³ãšæ¯èŒããã ãŠãµã®ã®çŒå åºè¡ã¯ãã¬ãŒã¶ãŒãŠããããçšã
ãŠèªçºããããååºç«å·ã¯ããŒã åºå200ã400ïœ
ããµã€ãº50ã100ãã¯ãã³ãç §å°æé0.1ã0.2s
ãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«äœããããæ¬
çºæã®è¬åã®æ²»çå¹æããžã·ãã³ã®ãããšå¯Ÿæ¯ã
ãç 究ã¯ãåã ïŒå¹ã®ïŒçŸ€ïŒå矀10çŒïŒã«åãã
ãã2.5ãïŒKgã®ãã³ãã©ç³»åã®10å¹ã®ãŠãµã®ã«
ã€ããŠè¡ãããã æ²»çã¯çŒåºåºè¡éå§åŸçŽã¡ã«éå§ããããæ¬çº
æã®è¬åã¯ãïŒïŒ 溶液0.5mlã®æäžéã§çŒçåŸæ¹
ããæ¯æ¥ïŒå15æ¥éã«äºã€ãŠæäžãããããžã·ã
ã³ã¯çŒçåŸæ¹ãã12.5ïŒ æº¶æ¶²0.5mlã®æäžéã§æ¯
æ¥ïŒå15æ¥éã«äºã€ãŠæ³šå°ãããã åºè¡éå§åŸïŒæ¥åŸã«ãæ¬çºæã®è¬åã§æ²»çãã
ãåç©ã«ãããŠã¯ãåºè¡åžåãé¡èã§ãããååº
ç«å·ã®è¿ãã®æµ®è «ã¯ãããŸã€ãã®ã«å¯Ÿãããžã·ã
ã³ãäžããããåç©çŸ€ã«ãããŠã¯ãçŒåºåºè¡ã®çš
床ã¯åºè¡éå§åŸïŒæ¥ã«èŠããããã®ãšå®è³ªäžåäž
ã®ç¶æ ã«ãšã©ãŸã€ãŠããã 14æ¥ç®ãŸã§ã«ã¯ãæ¬çºæã®è¬åã§æ²»çãããå
ç©ã¯å®å šãªåºè¡ã®åžåã瀺ããã®ã«å¯Ÿãããžã·ã
ã³ãåããåç©ã¯äŸç¶ãšããŠåºç¯ãªåºè¡ã®èšŒæ ã
瀺ããå®å šãªæ²»çã«ã¯25ã30æ¥éããã€ãã åŸã€ãŠãæ¬çºæã®è¬åã¯ããžã·ãã³ã«æ¯ã¹ãŠçŒ
å ã¬ãŒã¶ãŒâèªçºåºè¡ã®åžåã®é床ãèããå¢å€§
ããããšãã§ãããšçµè«ä»ããããšãã§ããã æŽã«åãå¥ã®ç 究ã§ã¯ãçŒå åºè¡åžåã®å¹çã«
é¢ããŠãæ¬çºæã®è¬åãšã¹ãã¬ãããã«ãŒãŒã察
æ¯ããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¬ãŒã¶ãŒãŠãããã
çšããŠèªçºããããååºç«å·ã¯ããŒã åºå200ã
400ïœïŒ·ããµã€ãº50ã100ãã¯ãã³ãç §å°æé0.1
ã0.2sãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«äœãã
ããæ¬çºæã®è¬åã®æ²»çå¹çãã¹ãã¬ãããã«ãŒ
ãŒã®ãããšå¯Ÿæ¯ããç 究ã¯ãåã ïŒå¹ã®ïŒçŸ€ïŒå
矀10çŒïŒã«åããããïŒãïŒKgã®ãã³ãã©ç³»åã®
10å¹ã®ãŠãµã®ã«ã€ããŠè¡ãããã æ²»çã¯å®éšåºè¡ã®éå§åŸçŽã¡ã«éå§ããããæ¬
çºæã®è¬åã¯ïŒïŒ 溶液0.5mlã®æäžéã§çŒçåŸæ¹
ããæ¯æ¥ïŒåã®æäžã§15æ¥éè¡ããããã¹ãã¬ã
ããã«ãŒãŒã¯çŒçåŸæ¹ããåºè¡éå§ãã0.5mlã®
æäžéã§ïŒåïŒæ¥æ¯ã«ïŒïŒmlåœã10000åäœïŒæ³š
å°ãããã åºè¡éå§åŸïŒæ¥ç®ã«æ¬çºæã®è¬åã§æ²»çããã
åç©ã«ãããŠåºè¡åžåãçžåœã«èŠãããã®ã«å¯Ÿ
ããã¹ãã¬ãããã«ãŒãŒãäžããããåç©çŸ€ã«ã
ããŠã¯åºè¡ã®çšåºŠã¯å®è³ªçã«æªå€åã®ãŸãã«ãšã©
ãŸã€ããããããªãããã¹ãã¬ãããã«ãŒãŒãäž
ããããåç©ã¯ãåºç¯ãªæµ®è «åã³ãŸã¶ãåã³çµè
ãåãçºèµ€ã®åœ¢æ ããšãæ確ãªæè¬ã«å¯Ÿããã¢ã¬
ã«ã®ãŒåå¿ã瀺ããããšãææãããã¹ãã§ã
ãã 14æ¥ç®ãŸã§ã«ãæ¬çºæã®è¬åã§æ²»çãããåç©
ã¯çŒåºåºè¡ã®å®å šãªåžåã瀺ãããåäžææã«ã¹
ãã¬ãããã«ãŒãŒãäžããããåç©ã¯çžåœãªåºè¡
ã®äºæ ã®èšŒæ ã瀺ããŠããã åŸã€ãŠãæ¬çºæã®è¬åã¯ã¹ãã¬ãããã«ãŒãŒãš
察æ¯ããŠçŒå åºè¡ã®åžåé床ãäžæãããããšã
ã§ãããšçµè«ä»ããããšãã§ããã æ¬çºæã®è¬åã®æ²»çå¹æãåæ§ã«ã¬ãŒã¶ãŒèªçº
çŒå åºè¡ã®å¯Ÿç §åç©ç 究ã«ãããŠè©äŸ¡ããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¢ã«ãŽã³ã¬ãŒã¶ãŒãŠ
ããããçšããŠèªçºããããååºç«å·ã¯ããŒã åº
å200ã400ïœïŒ·ããµã€ãº50ã100ãã¯ãã³ãç §å°
æé0.1ã0.2sãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«
äœããããçŒåºã®åçãã¬ããããªããŠããã
ïŒRetinophot unitïŒãçšããŠæ®ã€ããåç©ã«ã¯æ¬
çºæã®è¬åãæ¯æ¥åäžæäžïŒïŒïŒ 溶液0.3ã0.5
mlïŒã§15æ¥éçµèäžæãã¯çŒçåŸæ¹ããæäžã
ãã網èé»äœå³ïŒERGïŒãåç©ã®é èäžã«ç®äž
çã«å°å ¥ããåºæºé»æ¥µïŒéŒè£œéïŒåã³çµã¿èŸŒã¿é»
極ãæããã¬ã³ãºãçšããŠã€ã³ã¯æžã蟌ã¿è³é 圱
ãŠãããäžã«èšé²ãããå åºæã¯0.3Jã®åºååã³
ç¶ç¶æé50ïœïœã®ãã©ãã·ãŠãã«ãã«ããäžãã
ãããåæèªçºå¿çããã³ã·ã€ã«åã³ãªã·ãã¹ã³
ãŒãããã³ã·ã€ã«ã¯ãªã·ãã¹ã³ãŒãã¹ã¯ãªãŒã³ã®
ããŒãäžã«èšé²ãããããã©ãã·ãŠåœãã®æå¹ãš
ãã«ã®ãŒæ¶è²»ã¯180Jã§ããã350ããªç§ïŒïœïœïŒ
ç¶ç¶ããã40å¹ïŒå³ã¡80çŒïŒã«ãããæ²»çã¯ãã¬
ãŒã¶ãŒèªçºçŒå åºè¡åŸçŽã¡ã«éå§ããããïŒçŸ€ã®
å¯Ÿç §åç©ã䜿çšããããå³ã¡ã第ïŒã®çŸ€ã¯ãã©ã·
ãŒãïŒåœè¬ïŒåŠæ¹ã®ãã®ïŒ10å¹ã20çŒïŒã§ããã
第ïŒã®çŸ€ã¯æè¬ãªãã®ãã®ã§ãã€ãïŒ20å¹ã40
çŒïŒã å¯Ÿç §åç©åã³ç 究åç©ã®äž¡è ã«ãããŠãã¬ãŒã¶
ãŒååºåŸçŽã¡ã«åã³ïŒæ¥åŸã«ååºçŒåºé åè¿èŸºã®
åã³ç¡åäœã«å»¶åšãã網èåšèŸºåã³ç¶²èã®åºè¡ã®
城åãèŠãããããã®æå·ã¯ãæ¬çºæã®è¬åãæ
è¬ãããåç©ã«ãããŠã¯ããã軜ããã®ã§ãã€
ããåºè¡éå§åŸïŒæ¥åŸã«ç 究矀äžã®åç©ã¯æµ®è «ã
å®å šã«ãããŸããé¡èãªåºè¡ã®åžåã瀺ããã察
ç §åç©ã«ãããŠã¯ãåºè¡ã®çšåºŠã¯å®è³ªçã«å€åã
ãã網èè¡æ¶²ã®ç¡åäœãžã®æµåºã䌎ããããåç©
ã«ãããŠã¯éšåççŒçåºè¡ã圢æãããåºè¡éå§
åŸ14æ¥ç®ãŸã§ã«ãç 究ã°ã«ãŒãäžã®åç©ã¯åºè¡ã®
å®å šãªåžåãããã®ã«å¯Ÿããå¯Ÿç §åç©ã«ãããŠã¯
ããåç©ã«ãããŠã¯ç¡åäœã«åœ±é¿ãåãŒãç¶ç¶ç
網èåºè¡åã³éšåççŒçåºè¡ã®èšŒæ ãååšããã
å¯Ÿç §åç©ã«ãããåºè¡ã®å®å šãªåžåã¯1.0ã1.5ã±
æéã®æéã«äºã€ãã ãã®ããã«ãæ¬çºæã®è¬åã¯ãçŒå åºè¡ã®æ²»ç
ã«ãããŠãæçšãªåŒ·åãªæ²»çäœçšãæãããã®ã§
ãããå¯Ÿç §ïŒæªæ²»çïŒããã³å®éšïŒæ¬çºæã®è¬å
ã§æ²»çïŒåç©çŸ€ã«ãããé»æ°ççåŠçè©Šéšãè¡ã€
ãŠåºè¡äžã®ç¶²èã®æ©èœç¶æ ã®è©äŸ¡ãè¡ã€ãã é»æ°ççåŠçç 究ïŒç¶²èé»äœå³ïŒããåŸããã
çµæã第ïŒå³åã³ç¬¬ïŒå³ã«å³ç€ºãããïœæ³¢ã®çžå¯Ÿ
çæ¯å¹ ã瞊軞ã«ãããããïŒç¬¬ïŒå³ïŒãïœæ³¢ã®ã
ãã瞊軞ã«ãããããïŒç¬¬ïŒå³ïŒãããããåæ
網èé»äœå³ä¿¡å·ã®ïŒ ã§ç€ºããåºè¡éå§åŸã®æéçµ
éã暪軞ïŒåç¹ã60åã次ãã§ïŒæ¥ééã§14æ¥
éïŒã«ããããããã第ïŒå³åã³ç¬¬ïŒå³ã«ãããŠ
ïŒã§ç€ºãããæ²ç·ã¯å¯Ÿç §çŸ€ããã®çµæã§ãããïŒ
ã§ç€ºãããæ²ç·ã¯ç 究矀ïŒè¬åæ²»çïŒã®ãã®ã§ã
ãã é»æ°çååŠçè©Šéšã®çµæã§ã¯ãæ¬çºæã®è¬åã§
æ²»çãããªãåç©ïŒç¬¬ïŒå³åã³ç¬¬ïŒå³ã®æ²ç·ïŒïŒ
ã«ãããŠã¯ãERGä¿¡å·ã¯éãæå¶ãããããšã
瀺ããããè¬åæ²»çãããåç©ïŒç¬¬ïŒå³åã³ç¬¬ïŒ
å³ã®æ²ç·ïŒïŒã«ãããïœåã³ïœã®ERGæ²ç·ã¯10
ã15æ¥ç®ã«æ£åžžã«æ»ã€ãã®ã«å¯Ÿããéæè¬åç©ã«
ãããïœåã³ïœã®ERGæ²ç·ã¯åäžæç¹ã«ãããŠ
ããããå¯Ÿç §å€ã®37ã42ïŒ ã§ãã€ããéæè¬åç©
ã«ãããERGã¯æ²»çåç©ã®ããã«æ¯èŒããŠæ£åžž
ã«æ»ãã®ã«çžåœã«é·ãæéãèŠãã網èé»æ°ç掻
æ§ã®å®å šãªå埩ã¯1.5ãïŒã±æããã€ãŠè¡ãããã æªåŠçåç©ã«ãããåæèªçºå¿çããã³ã·ã€ã«
ïŒR2RRPã第ïŒå³ïŒ¡ïŒïŒïŒïŒãåçžåœã«å€åãã
ãã®æ¯å¹ ã¯åºè¡éå§åŸïŒæ¥ç®ãŸã§ã«æ£åžžå€ã®60ïŒ
ã«ãã¡ãã®ã«å¯Ÿããåæç¹ã«ãããŠè¬åã§æ²»çã
ãããŠãµã®ã«ãããR2RRPå€ã¯æ¢ã«åæã®æ°Žæº
ã«å°éããïŒç¬¬ïŒå³ïŒ¡ïŒïŒïŒïŒïŒãïŒæ¥ç®ãŸã§ã®ãª
ã·ãã¹ã³ãŒãããã³ã·ã€ã«å€ã¯ãåŠçåç©ã«ãã
ãŠãã®å¯Ÿç §æ°Žæºã«éæããã®ã«å¯ŸãïŒç¬¬ïŒå³ïŒ¢ïŒ
ïŒïŒïŒïŒãéæè¬åç©ã«ããããã®ããã³ã·ã€ã«ã®
çžå¯Ÿçæ¯å¹ ïŒç¬¬ïŒå³ïŒ¢ïŒïŒïŒïŒã¯å¯Ÿç §å€ã®60ã70
ïŒ ã§ãã€ãã第ïŒå³ïŒ¡ïŒïŒ¢ã¯èšé²ãããå åºæã
å³ç€ºãããã®ã§ããã åŸã€ãŠãæ¬çºæã®è¬åã¯ã網èæ©èœåã³çäœã
ãã³ã·ã€ã«ã«åœ±é¿ãåãŒãçŒå åºè¡é¢é£é害ã®åº
çŸãé²æ¢ããããšãã§ãããã®ã§ããã æ¬çºæã®è¬åã¯ãåçºæ§çŒå åºè¡ã®åžåãä¿é²
ããäœçšãæãããšå ±ã«æ°ãã«åŒãèµ·ããããåº
è¡ã«å¯ŸããçŒå æ§é ã«ä¿è·çå¹æãåãŒããã®ã§
ããã åŸâæäœæéåã³ã¬ãŒã¶ãŒååºåŸã«äœ¿çšããã
æ¬çºæã®è¬åã®ä¿è·ç¹æ§ãåãåç©å®éšã§è©äŸ¡ã
ããã¬ãŒã¶ãŒååºã¯ã¢ã«ãŽã³åã³ã¯ãªããã³ã¬ãŒ
ã¶ãŒãŠããããçšããŠè¡ããããååºç«å·ã¯ããŒ
ã åºå400ïœïŒ·ããµã€ãº200ãã¯ãã³ãç §å°æé
0.1ã0.2ïœïœãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«
äœããããçŒåºã®åçã¯ã¬ãããªããŠããããçš
ããŠæ®ããããå¯Ÿç §è©Šéšåã³ç 究詊éšã«çšããã
ãåç©ã®ç·æ°ã¯60å¹ïŒ120çŒãå矀60çŒïŒã§ãã€
ãã åç©ãäºé²ã¹ã±ãžãŠãŒã«ïŒïŒæ¥åã³æ¬¡ãã§ã¬ãŒ
ã¶ãŒååºåïŒæéïŒã«ãããæ¬çºæã®è¬åã«ãã
æ²»çã¯ïŒïŒ 溶液0.5mlã®æäžéã§æ¯æ¥ïŒåã10ã
15æ¥éæäžã§è¡ãªã€ãã å¯Ÿç §ïŒæªæ²»çïŒåã³è©ŠéšïŒæ²»çïŒåç©ã®ããã
ã«ãããŠãã¬ãŒã¶ãŒååºåŸçŽã¡ã«åã³ïŒæ¥åŸã«å
åºãããçŒåºé åã®è¿èŸºã«ãããŠæµ®è «ã®åŸŽåãã
ããããã¯äºé²æ²»çãåããªãã€ãåç©ã«ãããŠ
ããé¡èã§ãã€ããã¬ãŒã¶ãŒååºåã«æ¬çºæã®è¬
åã§åŠçãããåç©ã«ãããŠã¯ãçŒåºåºè¡ã®èªçº
ã¯å°é£ã§ãã€ããååºåŸïŒæ¥ç®ã«å¯Ÿç §çŸ€æãã¯è©Š
éšçŸ€ã®åç©ã®ãããã«ãããŠãååºç«å·çè²ã®èšŒ
æ ã¯ãªãã€ãã ãã®åŸå šãŠã®å¯Ÿç §åç©ã«ã€ããŠè¡ãããæ€çŒé¡
æ€æ»ã®çµæãååºç«å·ã®åšãã®æµ®è «ã¯ååºåŸïŒæ¥
ç®ãŸã§ãããŸããååºç«å·çè²ã¯åŒç¶ããŠèµ·ãã€
ãããšãã¿ãšããããããã®æ€çŒé¡æ€æ»ã®ç¥èŠã
ãæ¬çºæã®è¬åã§æ²»çãããªãåç©ã«ããã網è
ãžã®ç±çæå·ã®åŸŽåã¯ã¬ãŒã¶ãŒååºåŸïŒãïŒæ¥åŸ
ã«èµ·ãããã®ãšæšå®ãããã æ¬çºæã®è¬åã®ã¬ãŒã¶ãŒååºã«ããã䜿çšã¯ã¬
ãŒã¶ãŒæ²»çã«äŒŽã網èã®å埩å€åãèããä¿é²ã
ããæ¬çºæã®è¬åã«ããäºé²æ²»çãåããåç©ã®
æ€çŒé¡è©Šéšã¯ååºç«å·ã®é åã«ãããæµ®è «ã®åŸŽå
ã¯ïŒæ¥ç®ãŸã§ã«å®å šã«ãããŸããæœåšçååºç«å·
çè²ã¯åæã«é²è¡ãã¯ãããããšã瀺ããããã®
æ€çŒé¡è©Šéšã®ç¥èŠã«ããã°ãæ¬çºæã®è¬åãåã
åãåç©ã«ãããŠã¯ã網èååºç«å·ã®çè²ã¯ã¬ãŒ
ã¶ãŒååºåŸå¯Ÿç §çŸ€ã«ãããïŒãïŒæ¥ç®ã«å¯ŸããŠã
ïŒæ¥ç®ãŸã§ã«å®äºãããšããçµè«ãå°ãããã å¯Ÿç §çŸ€ïŒæªæ²»çïŒåã³è©ŠéšçŸ€ïŒäºé²çã«æ²»çïŒ
ã®åç©ã«ãããé»æ°ççåŠçè©Šéšãè¡ã€ãŠãã¬ãŒ
ã¶ãŒååºã«ããã網èã®æ©èœç¶æ ãè©äŸ¡ãããé»
æ°ççåŠç 究ïŒERGïŒããåŸãããçµæã¯ç¬¬ïŒ
å³ã«ç€ºããïœåã³ïœæ³¢ã®çžå¯Ÿçæ¯å¹ ã¯çžŠè»žã«ãã€
ã¯ããã«ãã§ããããããŠããã暪軞ã¯åºè¡éå§
åŸã®çµéæéããããããããã®ã§ããïŒåç¹â
60åã次ãã§ïŒæ¥ééã§14æ¥éïŒã第ïŒå³ã«ãã
ãé»æ°ççåŠççµæã§ã¯ãäºé²åã³ããã«åŒç¶ã
è¬åæ²»çãè¡ãããŠããåç©ã«ãããŠïœåã³ïœæ³¢
ã¯10ã15æ¥ç®ãŸã§ã«æ£åžžã«æ»ã€ãããšã瀺ããã
åäžæéãŸã§ã«éæè¬åç©ã«ãããïœåã³ïœïŒïŒ©ïŒ
ERGæ³¢ã®æ¯å¹ ã¯å¯Ÿç §å€ã®å ãã«60ïŒ ã§ãã€ãã éâæè¬åç©ã«ãããERGã¯æ¬çºæã®è¬åã®
äºé²çåã³ããã«åŒç¶ãåŠæ¹ãåããŠããåç©ã®
ããã«å¯Ÿæ¯ããŠæ£åžžã«æ»ãã®ã«çžåœã«é·ãæéã
ããã€ãããšã匷調ãããã¹ãã§ãããå¯Ÿç §åç©
ïŒè¬åç¡æäžïŒã«ãããERGæ³¢ã®å®å šãªå埩ã¯1.5
ãïŒã±æã®æéã«äºã€ãŠçããã ãã®ããã«ãæ¬çºæã®è¬åã¯ãã¬ãŒã¶ãŒååºã«
ãããŠäºé²çäœçšã®åããããæ£åžžç¶²èæ©èœãä¿
åããã¬ãŒã¶ãŒååºåŸç¶²èã«ãããåçå€åãä¿
é²ãããã€ç¶²èåºè¡ãäºé²ããããšãã§ãããã®
ã§ããã æ¬çºæã®è¬åã®æ²»çå¹çãã¬ãŒã¶ãŒèªçºç¶²èç«
å·ã«ãããŠç 究ããã äžé£ã®å®éšãäœéïŒã3.5Kgã®ãã³ãã©ç³»åã®
20å¹ã®ãŠãµã®ã«ã€ããŠè¡ã€ããã¬ãŒã¶ãŒç«å·ã¯ã¢
ã«ãŽã³ã¬ãŒã¶ãŒãŠããããçšããŠèªçºãããçŒåº
ç«å·ã¯ããŒã åºå600ïœïŒ·ããµã€ãº500ÎŒãç §å°æ
é0.1ã0.2sãçšããŠåç©ã®èŠç¥çµå¹³åç€ç¶çµç¹ã®
äžã«äœã€ããåŒç¶ãç¶æ å€åã®èŠå¯ã¯éæ¥æ€çŒé¡
æ€æ»æ³åã³ã¬ããããªãåçãçšããŠè¡ã€ãã察
ç §åç©çŸ€ã¯ãè¬åãå šãåãåããªãã€ããç 究
矀ã®åç©ã¯ãæ¬çºæã®è¬åãïŒïŒ 溶液0.5mlã®æ
äžéãããªãæ²»çåŠæ¹ããåç©ã®ç®ã«ãããŠç¶²è
æå·ããããŠããïŒæ¥éã«äºã€ãŠçŒçåŸæ¹ããã®
泚å°ã«ããåãåã€ããå¯Ÿç §åã³ç 究åç©ã®ãã
ãã«ãããŠã網èç«å·ã®èªçºåŸçŽã¡ã«å®æœçŒåºé
åã«ãããŠæã ã«å°ããªåºè¡ã䌎ãæ確ãªæµ®è «ã®
城åãèŠããããç 究åç©ã«ãããŠã¯ãç«å·èªçº
åŸïŒæ¥ç®ã«åçã«æžå°ãã滲åºæŽ»æ§ã®èšŒæ ãèŠã
ããïŒãïŒæ¥ç®ãŸã§ã«ã¯å®å šã«ãããŸããçè²ã
ãå·è·¡ãç«å·ç®æã«ïŒãïŒæ¥ç®ãŸã§ã«åœ¢æãã
ãã å¯Ÿç §çŸ€ã®åç©ïŒæªæ²»çïŒã«ãããŠãïŒãïŒæ¥ç®
ã«è¡ãããæ€çŒé¡æ€æ»ã§ã¯æµ®è «åã³éå®ãããåº
è¡ã®åŸŽåãèŠããããïŒæ¥ç®ãŸã§ã«ã¯æã ã«æµ®è «
ã®æžå°ãèŠãããååºç«å·ã®åæã®éšåççè²åŸŽ
åã䌎ããã®ã§ãã€ããå¯Ÿç §åç©ïŒæªæ²»çïŒã«ã
ããååºç«å·ã®å®å šçè²ã¯å¹³åããŠ14æ¥ç®ãŸã§ã«
èµ·ã€ãã çµè«ãšããŠãæ¬çºæã®è¬åã¯ã¬ãŒã¶ãŒèªçºç¶²è
ç«å·ã®æ²»çã«ãããŠæçšãªåŒ·åãªæ²»çå€ãšããã
ãšãã§ããã ã¬ãŒã¶ãŒèªçºçŒå åºè¡ã®çäŸã«ãããŠè¡æµçŒç
éåæ³ãçšããŠçŒã®è¡è¡ååŠãç 究ããã ãŠãµã®ã«ãããçŒå åºè¡ã¯ã¬ãŒã¶ãŒãŠãããã
çšããŠèªçºãããååºç«å·ã¯ããŒã åºå200ã400
ïœïŒ·ããµã€ãº50ã100ÎŒãç §å°æé0.1ã0.2ç§ãçš
ããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äžã«äœã€ããçŒåºãã¬
ããããªããŠããããçšããŠåçæ®åœ±ãããåç©
ã¯ãæ¬çºæã®è¬åã®ïŒïŒ 溶液ïŒ50mlïŒã§åºè¡éå§
ã®æ¥ããå§ããŠæ¯æ¥äžåæ²»çã®å šæéïŒ15æ¥ïŒçŒ
çåŸæ¹ããæäžããŠæ²»çãããè¡æµçŒçéåã¯L.
A.ã«ãããã«ãœã³ïŒL.A.KatsnelsonïŒæ³ã«ãã
é»æ°è³é 圱æ®åœ±ãŠãããã«åãä»ããã¬ãªã°ã©ã
è£ çœ®ãçšããŠè¡ã€ããã¬ãªã°ã©ãå åã¯æ¬¡åŒãçš
ããŠèšç®ããã RqïŒïŒ¡ã»Ewã»1000ïŒEzã»ïŒ² ãåŒäžïŒ¡ã¯ãã«ã¹æ³¢æ¯å¹ ïŒmmïŒã Ewã¯èŒæ£ãã«ã¹ã§ããïŒãªãŒã ïŒã ã¯é»æ¥µæµæïŒã€ã³ããŒãã³ã¹ïŒïŒãªãŒã ïŒ ã§ããã Ezã¯èŒæ£ãã«ã¹ïŒmmïŒã§ãããã çµæïŒè¡šïŒïŒã®è©äŸ¡ã¯ãçŒå åºè¡ã¯éãæžå°ã
ãè¡æµçŒçéåæ¯å¹ ãçãããã®çµæãåºè¡éå§
åŸïŒæéçšã®æ©ãææã«ã¬ãªã°ã©ãå åRqã¯å¯Ÿ
ç §å€ã®50ïŒ ãŸã§äœäžããããšã瀺åããŠãããã
ã®è¡æµçŒçéåå³ã«ãããæžè¡°ã¯æ¯èŒçå®å®ãã
æ§è³ªãæããRqå€ã¯åºè¡éå§åŸ14æ¥ç®ã«ãäœç
ã®å€åã瀺ããªãããŠãµã®ã«ãããç®ã®è管路ã«
ãããè¡è¡ååŠã¯åºè¡éå§åŸïŒé±éã§éå§ããå
埩ãžã®ãã€ããããé²è·¯ãåããã®çµæ30æ¥çµé
åŸã«ã¬ãªã°ã©ãå åã¯å¯Ÿç §å€ã®56ïŒ ãŸã§ã«äžæã
ããè¡æµçŒçéåå³ã®å®å šãªæ£åžžåã¯åºè¡éå§åŸ
1.0ã1.5ã±æåŸã«éåžžèµ·ãããç 究çµæãè¡šïŒã«
ãŸãšããŠç€ºãã
ãè¡šã
ã¬ãŒã¶ãŒèªçºçŒå
åºè¡ã®åžåãžã®æ²»çå¹æã®ç
究ã«ã€ããŠãæ¬çºæã®ïŒïŒ 溶液ã®è¬åãšãã¿ãã³
B6ã®ïŒïŒ 溶液ãæ¯èŒããããã¿ãã³B6ã¯æ¬çºæ
ã®è¬åãšæ§é çã«é¡äŒŒã§ããã®ã§ãããã®æ²»çå¹
æãæ¯èŒããã®ãé©åœã§ãããšå€æããããïŒçŸ€
ã®åç©ãæ¬çºæã®0.1ïŒ æº¶æ¶²ïŒ0.5mlïŒåã³ãã¿ã
ã³B6ïŒïŒïŒ 溶液0.6mlïŒãçšããŠãåºè¡ã®éå§æ¥ã
ãå§ããŠæ¯æ¥äžåæ²»çæéïŒ15æ¥ïŒã«äºãçŒçåŸ
æ¹ããã®æ³šå°ã«ããæäžããŠæ²»çãããå¯Ÿç §äŸãš
ããŠéžã°ããåç©ã«ã¯ããã©ã·ãŒãåŠæ¹ïŒ0.5mlã
çªå·15ïŒãäžãããåŸãããçµæãè¡šïŒã«ç€ºãã ç 究äžã®åç©ã«ãããçŒè管路ã®è¡è¡ååŠã®è©
䟡ã§ã¯B6åŠæ¹ãäžãããã矀ããåŸãããè¡æµ
çŒçéåå³ãã©ã¡ãŒã¿ãŒã¯çµ±èšçã«ç¢ºå®æ§ãç«èšŒ
ãããŠããæªæ²»çåã³ãã©ã·ãŒãåé 矀ã®åç©ã®
äž¡è ã«ãããããããšåäžã§ããããšãæŽã«èšŒæ
ãããã æ€çŒé¡æ€æ»ã®ç¥èŠã¯ãã¿ãã³B6ãå©çšããæ²»
çã¯çŒå åºè¡åžåã®é床ã«åœ±é¿ãäžããªããšãã
äºå®ã瀺ããŠããããã®çŸ€ã®åç©ã«ãããåºè¡ã®
å®å šãªåžåã¯30ã45æ¥ç®ãŸã§ã«èµ·ããããã®ç¹ã«
ãããŠãããã¯å¯Ÿç §äŸãšè¿äŒŒãããã®ã§ãã€ãã æ¬çºæã®è¬åã«ããæ²»çã«å¯Ÿå¿ããŠãçŒå åºè¡
åžåã®æéã¯å¯Ÿç §äŸã«æ¯èŒããŠãçžåœã«ççž®ãã
ããå³ã¡ãåºè¡éå§åŸïŒæ¥ç®ã«æ¬çºæã®è¬åã§æ²»
çãããåç©ã«ãããŠã¯ãçŒåºåºè¡ã®çžåœãªåžå
ã®åŸŽåããããããã¯14æ¥ç®ãŸã§ã«å®è³ªçã«å®å š
ã«å®çµããã®ã«å¯Ÿããå¯Ÿç §çŸ€ïŒæªæ²»çåã³ãã©ã·
ãŒãæ²»çïŒåã³ãã¿ãã³B6ãäžãããã矀ã«ã
ããŠã¯ãæªã å€éã®ç¶²èåã³ç¡åäœåºè¡ããã€
ãã è¬åæ²»çãããåç©çŸ€ã«ãããåºè¡éå§ãã24
æéã«èªããããã¬ãªã°ã©ãææ°å€åã¯åæå€ã®
82ïŒ ã§ãã€ãã®ã«å¯Ÿããå¯Ÿç §çŸ€åã³ãã¿ãã³B6
ãåãåã€ã矀ã«ãããŠã¯ããããã®ææ°ã¯äœ
äžãå³ã¡ãã¬ãªã°ã©ãææ°Rqã¯åã åæå¯Ÿç §å€
ã®59ïŒ ã61ïŒ ã§ãã€ããæ¬çºæã®è¬åãäžããã
ãåç©çŸ€ã«ãããè¡æµçŒçéåå³ã®å埩ã¯ïŒãïŒ
æ¥ç®ã«èµ·ãã€ãã®ã«å¯Ÿããå¯Ÿç §äŸåã³ãã¿ãã³
B6矀ã«ãããŠã¯ãåäžã®æ¹è¯ã¯åºè¡éå§ããïŒ
ã1.5ã±æã®çµããŸã§ã«èŠãããã®ã¿ã§ãã€ãã åŸã€ãŠããããã®äžé£ã®å®éšã¯ãçŒå åºè¡ãç®
ã®è¡è¡ååŠã«å¥œãŸãããªã圱é¿ãåãŒãããšã瀺
ãããæ¬çºæã®è¬åã¯B6ãšã¯å¯Ÿç §çã«çŒå åºè¡
åžåã®é床ãäžæãããç®ã®è¡è¡ååŠã®å埩èœå
ãæããã æ¬çºæã®è¬åã®ç¶²èé žçŽ ä»å åã³çäœããã³ã·
ã€ã«ã®å¹æãæããã«ããæ€èšåªåããªãããã
ãã®ç¶²èäžã§èµ·ããé žååã³çäœé»æ°éçšã®ç 究
ã¯é·æå®éšã«åºã¥ããŠãŠãµã®ã®ç¶²èã®é žçŽ é»å§
ïŒããŒã©ãã°ã©ãã€ãŒïŒåã³çäœããã³ã·ã€ã«ã
èšé²ããããšã«ããåæã«è¡ãããããã®ç®çã®
ããã«ãçŽåŸ130ÎŒïœã®ïŒŽåçœéé»æ¥µã匷èãé
ããŠãŠãµã®ã®ç®ã®äžã®çŒçèµ€éã«åŸ®å°ããžãçšã
ãŠå°å ¥ãããé»æ¥µã®ç¶²èäžãžã®æ¿å ¥ãæ£ããç£èŠ
ããããã«ç 究å®äºåŸåç©ããæåºããç®ãçµç¹
åŠçæ€æ»ã«ä»ããã
究ã«ã€ããŠãæ¬çºæã®ïŒïŒ 溶液ã®è¬åãšãã¿ãã³
B6ã®ïŒïŒ 溶液ãæ¯èŒããããã¿ãã³B6ã¯æ¬çºæ
ã®è¬åãšæ§é çã«é¡äŒŒã§ããã®ã§ãããã®æ²»çå¹
æãæ¯èŒããã®ãé©åœã§ãããšå€æããããïŒçŸ€
ã®åç©ãæ¬çºæã®0.1ïŒ æº¶æ¶²ïŒ0.5mlïŒåã³ãã¿ã
ã³B6ïŒïŒïŒ 溶液0.6mlïŒãçšããŠãåºè¡ã®éå§æ¥ã
ãå§ããŠæ¯æ¥äžåæ²»çæéïŒ15æ¥ïŒã«äºãçŒçåŸ
æ¹ããã®æ³šå°ã«ããæäžããŠæ²»çãããå¯Ÿç §äŸãš
ããŠéžã°ããåç©ã«ã¯ããã©ã·ãŒãåŠæ¹ïŒ0.5mlã
çªå·15ïŒãäžãããåŸãããçµæãè¡šïŒã«ç€ºãã ç 究äžã®åç©ã«ãããçŒè管路ã®è¡è¡ååŠã®è©
䟡ã§ã¯B6åŠæ¹ãäžãããã矀ããåŸãããè¡æµ
çŒçéåå³ãã©ã¡ãŒã¿ãŒã¯çµ±èšçã«ç¢ºå®æ§ãç«èšŒ
ãããŠããæªæ²»çåã³ãã©ã·ãŒãåé 矀ã®åç©ã®
äž¡è ã«ãããããããšåäžã§ããããšãæŽã«èšŒæ
ãããã æ€çŒé¡æ€æ»ã®ç¥èŠã¯ãã¿ãã³B6ãå©çšããæ²»
çã¯çŒå åºè¡åžåã®é床ã«åœ±é¿ãäžããªããšãã
äºå®ã瀺ããŠããããã®çŸ€ã®åç©ã«ãããåºè¡ã®
å®å šãªåžåã¯30ã45æ¥ç®ãŸã§ã«èµ·ããããã®ç¹ã«
ãããŠãããã¯å¯Ÿç §äŸãšè¿äŒŒãããã®ã§ãã€ãã æ¬çºæã®è¬åã«ããæ²»çã«å¯Ÿå¿ããŠãçŒå åºè¡
åžåã®æéã¯å¯Ÿç §äŸã«æ¯èŒããŠãçžåœã«ççž®ãã
ããå³ã¡ãåºè¡éå§åŸïŒæ¥ç®ã«æ¬çºæã®è¬åã§æ²»
çãããåç©ã«ãããŠã¯ãçŒåºåºè¡ã®çžåœãªåžå
ã®åŸŽåããããããã¯14æ¥ç®ãŸã§ã«å®è³ªçã«å®å š
ã«å®çµããã®ã«å¯Ÿããå¯Ÿç §çŸ€ïŒæªæ²»çåã³ãã©ã·
ãŒãæ²»çïŒåã³ãã¿ãã³B6ãäžãããã矀ã«ã
ããŠã¯ãæªã å€éã®ç¶²èåã³ç¡åäœåºè¡ããã€
ãã è¬åæ²»çãããåç©çŸ€ã«ãããåºè¡éå§ãã24
æéã«èªããããã¬ãªã°ã©ãææ°å€åã¯åæå€ã®
82ïŒ ã§ãã€ãã®ã«å¯Ÿããå¯Ÿç §çŸ€åã³ãã¿ãã³B6
ãåãåã€ã矀ã«ãããŠã¯ããããã®ææ°ã¯äœ
äžãå³ã¡ãã¬ãªã°ã©ãææ°Rqã¯åã åæå¯Ÿç §å€
ã®59ïŒ ã61ïŒ ã§ãã€ããæ¬çºæã®è¬åãäžããã
ãåç©çŸ€ã«ãããè¡æµçŒçéåå³ã®å埩ã¯ïŒãïŒ
æ¥ç®ã«èµ·ãã€ãã®ã«å¯Ÿããå¯Ÿç §äŸåã³ãã¿ãã³
B6矀ã«ãããŠã¯ãåäžã®æ¹è¯ã¯åºè¡éå§ããïŒ
ã1.5ã±æã®çµããŸã§ã«èŠãããã®ã¿ã§ãã€ãã åŸã€ãŠããããã®äžé£ã®å®éšã¯ãçŒå åºè¡ãç®
ã®è¡è¡ååŠã«å¥œãŸãããªã圱é¿ãåãŒãããšã瀺
ãããæ¬çºæã®è¬åã¯B6ãšã¯å¯Ÿç §çã«çŒå åºè¡
åžåã®é床ãäžæãããç®ã®è¡è¡ååŠã®å埩èœå
ãæããã æ¬çºæã®è¬åã®ç¶²èé žçŽ ä»å åã³çäœããã³ã·
ã€ã«ã®å¹æãæããã«ããæ€èšåªåããªãããã
ãã®ç¶²èäžã§èµ·ããé žååã³çäœé»æ°éçšã®ç 究
ã¯é·æå®éšã«åºã¥ããŠãŠãµã®ã®ç¶²èã®é žçŽ é»å§
ïŒããŒã©ãã°ã©ãã€ãŒïŒåã³çäœããã³ã·ã€ã«ã
èšé²ããããšã«ããåæã«è¡ãããããã®ç®çã®
ããã«ãçŽåŸ130ÎŒïœã®ïŒŽåçœéé»æ¥µã匷èãé
ããŠãŠãµã®ã®ç®ã®äžã®çŒçèµ€éã«åŸ®å°ããžãçšã
ãŠå°å ¥ãããé»æ¥µã®ç¶²èäžãžã®æ¿å ¥ãæ£ããç£èŠ
ããããã«ç 究å®äºåŸåç©ããæåºããç®ãçµç¹
åŠçæ€æ»ã«ä»ããã
ãè¡šã
å®éšã®ç¥èŠã§ã¯ãŠãµã®ã®ç®ã®éšåã®çµç¹åŠçå€
芳ã匷èåã³ç²èã貫éããå·ã®éå£éšã網èã§
çµäºããŠããããšãå³ã¡ãæ€ã蟌ãã é»æ¥µã®æ«ç«¯
ã網èã«å®éã«åœã€ãŠããããããç¡å·ã«ããŠã
ããå Žåã«è©äŸ¡å¯èœãªãã®ã§ãããšå€æãããã ããŒã©ãã°ã©ãåæã®ããã«ããã®ç 究ã¯
0.6Vã«çããé žçŽ åâæ³¢ããã³ã·ã€ã«äžŠã³ã«é ž
çŽ é»å§ã«æ¯äŸããçžåœã®æ¡æ£é»æµãçæããå éš
çŽæµé»æ°åè·¯ãæããçœéâéã«ããã«ãçšã
ãã 30ç§ç¶ç¶ããçæéå¶åŸ¡é žçŽ åžå ¥ïŒæšæºç°å¢
å ïŒãé žçŽ è©Šéšè©ŠæãšããŠç¶²èæ©èœãå®æ§çã«è©
䟡ããã®ã«çšãããããããŒã©ãã°ã©ã ããŒã¿ã
çšããŠæ¬¡ã®ææ°ãèšç®ããã (1) æœåšæéïŒÏïŒâé žçŽ äŸçµŠéå§ããããŒã©ã
ã°ã©ã äžæéå§ãŸã§ã®æé (2) é«ã(H)âããé žçŽ è©Šæã«å¯Ÿããæé«ããŒã©ã
ã°ã©ãæ³¢é«åºŠ (3) 網èçµç¹äžã®é žçŽ å©çšé床âããŒã©ãã°ã©ã
æ²ç·ã®åŸæå±æ²ã«å¯ŸããŠæ¥ç·æ¹åã®çŽç·ã«ãã
圢æãããåŸæè§åºŠã®ã¿ã³ãžãšã³ãïŒtan뱕Π(4) æ¯ïœïŒH100ïŒ ãšããŠèšç®ããæ¬çºæã®è¬å
ã®å°å ¥åŸã®é žçŽ æ倱(h)ã ããŒã©ãã°ã©ã ã第ïŒå³ã«ç€ºãã é žçŽ è©Šæãæå¹ã«æ®åããæéãããŒã©ãã°ã©
ã ã®åºéšã«ç€ºãã ERGã¯ã網èäžã«æ€ã蟌ãã é»æ¥µåã³åç©ã®
é ã®ç®äžã«å°å ¥ããåºæºé»æ¥µïŒéŒè£œéïŒããè³é
圱ãŠãããäžã«èšé²ãããå åºæã¯ããã©ãã·ãŠ
é»å0.3JãçšããŠãœãã¯ã«ïŒSonocleïŒãã«ã¹åº
ææ©ã«ããäžãããããæ¬çºæã®è¬åãå©çšãã
åç©ã®æ²»çã¯ãã¬ãŒã¶ãŒååºåŸç¬¬ïŒæ¥ç®ã«0.63
mgïŒKgã®æäžéã§éèå åã³çŒçåŸæ¹æäžã«ã
ããåæ§ã«ïŒã10mgïŒKgã®æäžéã§0.2ïŒ æº¶æ¶²ã®
ç¹æ»Žæ³šå ¥ã«ããçµèå¢äžã«çèå æäžããŠè¡ãã
ãã å¯Ÿç §åç©ã«ãããããŒã©ãã°ã©ãã€ã®çµæã¯ã
æ¬çºæã®è¬åã¯ç¶²èå ã«ãããé žçŽ å©çšã®é床ã
é ããããæ¬çºæã®è¬åå°å ¥åŸã®é žçŽ æ倱ã¯16ïŒ
ã42ïŒ ã®ç¯å²ã«èœã¡ãïŒè¡šïŒïŒãšããããšã瀺ã
ããæœåšæéåã³ããŒã©ã°ã©ã ã®æ¯å¹ ã¯å€§å€æ°ã®
å®éšã«ãããŠäœãå€åããªãã€ãïŒè¡šïŒïŒãå¹ç
ã®ããŒã¯ã¯è¬åæäžåŸ20ã30ååŸã«èŠããããç
究ã®ãã©ã¡ãŒã¿ã«ããå€æãããšããã®è¬åã¯å°
å ¥åŸïŒã1.5æéæå¹ã«çãŸãã 網èé»å³èšé²ã®ç¥èŠãè¡šïŒã«ç€ºããæ¬çºæã®è¬
åã®å°å ¥ã«å¯Ÿå¿ããŠ10ã20å以å ã«âïœâåã³
âïœâERGæ³¢æ¯å¹ ã¯ãïœæ³¢ã«ã€ããŠã¯28.2±
4.8ÎŒVãã48.4±8.5ÎŒVïŒïœïŒ0.01ïŒïŒ70ïŒ ïŒã«ãïœ
æ³¢ã«ã€ããŠã¯111±13.4ÎŒVãã144±13.6ÎŒVïŒïœïŒ
0.02ïŒïŒ30ïŒ ïŒã«çµ±èšçã«èšŒæãããå¢å€§ã瀺ã
ãããšã«æ³šç®ããããã çµè«ãšããŠãERGåã³ããŒã©ãã°ã©ãïŒåæ
ã«èšé²ïŒããåŸãããç¥èŠã§ã¯ã網èã«ãããæž
å°ããé žçŽ å©çšã«ãæãããïœåã³bERGæ³¢æ¯å¹
ã®ããããæ¬çºæã®è¬åã®æäžåŸå¢å€§ããããšã
瀺ããŠããã
芳ã匷èåã³ç²èã貫éããå·ã®éå£éšã網èã§
çµäºããŠããããšãå³ã¡ãæ€ã蟌ãã é»æ¥µã®æ«ç«¯
ã網èã«å®éã«åœã€ãŠããããããç¡å·ã«ããŠã
ããå Žåã«è©äŸ¡å¯èœãªãã®ã§ãããšå€æãããã ããŒã©ãã°ã©ãåæã®ããã«ããã®ç 究ã¯
0.6Vã«çããé žçŽ åâæ³¢ããã³ã·ã€ã«äžŠã³ã«é ž
çŽ é»å§ã«æ¯äŸããçžåœã®æ¡æ£é»æµãçæããå éš
çŽæµé»æ°åè·¯ãæããçœéâéã«ããã«ãçšã
ãã 30ç§ç¶ç¶ããçæéå¶åŸ¡é žçŽ åžå ¥ïŒæšæºç°å¢
å ïŒãé žçŽ è©Šéšè©ŠæãšããŠç¶²èæ©èœãå®æ§çã«è©
䟡ããã®ã«çšãããããããŒã©ãã°ã©ã ããŒã¿ã
çšããŠæ¬¡ã®ææ°ãèšç®ããã (1) æœåšæéïŒÏïŒâé žçŽ äŸçµŠéå§ããããŒã©ã
ã°ã©ã äžæéå§ãŸã§ã®æé (2) é«ã(H)âããé žçŽ è©Šæã«å¯Ÿããæé«ããŒã©ã
ã°ã©ãæ³¢é«åºŠ (3) 網èçµç¹äžã®é žçŽ å©çšé床âããŒã©ãã°ã©ã
æ²ç·ã®åŸæå±æ²ã«å¯ŸããŠæ¥ç·æ¹åã®çŽç·ã«ãã
圢æãããåŸæè§åºŠã®ã¿ã³ãžãšã³ãïŒtan뱕Π(4) æ¯ïœïŒH100ïŒ ãšããŠèšç®ããæ¬çºæã®è¬å
ã®å°å ¥åŸã®é žçŽ æ倱(h)ã ããŒã©ãã°ã©ã ã第ïŒå³ã«ç€ºãã é žçŽ è©Šæãæå¹ã«æ®åããæéãããŒã©ãã°ã©
ã ã®åºéšã«ç€ºãã ERGã¯ã網èäžã«æ€ã蟌ãã é»æ¥µåã³åç©ã®
é ã®ç®äžã«å°å ¥ããåºæºé»æ¥µïŒéŒè£œéïŒããè³é
圱ãŠãããäžã«èšé²ãããå åºæã¯ããã©ãã·ãŠ
é»å0.3JãçšããŠãœãã¯ã«ïŒSonocleïŒãã«ã¹åº
ææ©ã«ããäžãããããæ¬çºæã®è¬åãå©çšãã
åç©ã®æ²»çã¯ãã¬ãŒã¶ãŒååºåŸç¬¬ïŒæ¥ç®ã«0.63
mgïŒKgã®æäžéã§éèå åã³çŒçåŸæ¹æäžã«ã
ããåæ§ã«ïŒã10mgïŒKgã®æäžéã§0.2ïŒ æº¶æ¶²ã®
ç¹æ»Žæ³šå ¥ã«ããçµèå¢äžã«çèå æäžããŠè¡ãã
ãã å¯Ÿç §åç©ã«ãããããŒã©ãã°ã©ãã€ã®çµæã¯ã
æ¬çºæã®è¬åã¯ç¶²èå ã«ãããé žçŽ å©çšã®é床ã
é ããããæ¬çºæã®è¬åå°å ¥åŸã®é žçŽ æ倱ã¯16ïŒ
ã42ïŒ ã®ç¯å²ã«èœã¡ãïŒè¡šïŒïŒãšããããšã瀺ã
ããæœåšæéåã³ããŒã©ã°ã©ã ã®æ¯å¹ ã¯å€§å€æ°ã®
å®éšã«ãããŠäœãå€åããªãã€ãïŒè¡šïŒïŒãå¹ç
ã®ããŒã¯ã¯è¬åæäžåŸ20ã30ååŸã«èŠããããç
究ã®ãã©ã¡ãŒã¿ã«ããå€æãããšããã®è¬åã¯å°
å ¥åŸïŒã1.5æéæå¹ã«çãŸãã 網èé»å³èšé²ã®ç¥èŠãè¡šïŒã«ç€ºããæ¬çºæã®è¬
åã®å°å ¥ã«å¯Ÿå¿ããŠ10ã20å以å ã«âïœâåã³
âïœâERGæ³¢æ¯å¹ ã¯ãïœæ³¢ã«ã€ããŠã¯28.2±
4.8ÎŒVãã48.4±8.5ÎŒVïŒïœïŒ0.01ïŒïŒ70ïŒ ïŒã«ãïœ
æ³¢ã«ã€ããŠã¯111±13.4ÎŒVãã144±13.6ÎŒVïŒïœïŒ
0.02ïŒïŒ30ïŒ ïŒã«çµ±èšçã«èšŒæãããå¢å€§ã瀺ã
ãããšã«æ³šç®ããããã çµè«ãšããŠãERGåã³ããŒã©ãã°ã©ãïŒåæ
ã«èšé²ïŒããåŸãããç¥èŠã§ã¯ã網èã«ãããæž
å°ããé žçŽ å©çšã«ãæãããïœåã³bERGæ³¢æ¯å¹
ã®ããããæ¬çºæã®è¬åã®æäžåŸå¢å€§ããããšã
瀺ããŠããã
ãè¡šã
ãè¡šã
æ¬çºæã®è¬åã®ç¶²èé
žçŽ ä»å ã«åãŒã圱é¿ã¯ã
è©Šéšåç©ã®ç¶²èåšå®ãçŽæ¥çã«ã¢ã«ãŽã³ã¬ãŒã¶ãŒ
ç §å°ã«æé²ããããšã«ããåŒãèµ·ããããå®éšç
ã«èªçºãããçŒå åºè¡ã«ãããŠç 究ãããååºç«
å·ã¯ããŒã åºå500ïœïŒ·ããµã€ãº50ã100ÎŒãç §å°
æé0.1ã0.2ç§ãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äž
ã«ããããããã第ïŒå³ã¯ãå¥åº·ãªãŠãµã®ïŒïŒ
åã³ã¢ã«ãŽã³ã¬ãŒã¶ãŒã«ãã圢æãããçŒå åºè¡
ã«ããã€ããŠãµã®ïŒïŒãžã®è¬åæäžãè¡ã€ãåŸ
ã®é žçŽ å©çšã«ã€ããŠã®ç 究ããã®å®éšçç¥èŠããŸ
ãšããŠç€ºããã®ã§ãããåå³ã¯ååæ§ã«åæããŒ
ã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬åå°å ¥åã®ãŠãµã®ç¶²
èã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬åå°å ¥åŸ15
ååŸã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯æ³šå°åŸ55å
åŸã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯åºè¡éå§åã®
ãŠãµã®ç¶²èã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬å
æ²»çãªãã®åºè¡éå§ããïŒæ¥ç®ã®ãŠãµã®ç¶²èã®ã
ãŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬åæ²»çã«ããå€æ§
ãããåºè¡éå§ããã®ãŠãµã®ç¶²èã®ããŒã©ãã°ã©
ã ã瀺ãã å€ãã®ç 究ããã®ç¥èŠã¯ãã¬ãŒã¶ãŒååºã¯ç¶²è
ã«ãããé žçŽ å©çšãæå·ããã¬ãŒã¶ãŒååºåŸã®ïŒ
æ¥ç®ã®é žçŽ å©çšé床ã1.0ãã0.17ã«äœäžãã
ïŒå¯Ÿç §ã«æ¯èŒããŠïŒåã®æžå°ïŒãé žçŽ æ倱ã¯70ïŒ ã«
éããããšã瀺ããŠãããã¬ãŒã¶ãŒååºããïŒâ
ïŒæ¥ç®ã«ç¶²èé žçŽ å©çšã¯æ£åžžã«æ»ãããšãèªãã
ããïŒçµæãè¡šïŒã«ç€ºãïŒã
è©Šéšåç©ã®ç¶²èåšå®ãçŽæ¥çã«ã¢ã«ãŽã³ã¬ãŒã¶ãŒ
ç §å°ã«æé²ããããšã«ããåŒãèµ·ããããå®éšç
ã«èªçºãããçŒå åºè¡ã«ãããŠç 究ãããååºç«
å·ã¯ããŒã åºå500ïœïŒ·ããµã€ãº50ã100ÎŒãç §å°
æé0.1ã0.2ç§ãçšããŠèŠç¥çµå¹³åç€ç¶çµç¹ã®äž
ã«ããããããã第ïŒå³ã¯ãå¥åº·ãªãŠãµã®ïŒïŒ
åã³ã¢ã«ãŽã³ã¬ãŒã¶ãŒã«ãã圢æãããçŒå åºè¡
ã«ããã€ããŠãµã®ïŒïŒãžã®è¬åæäžãè¡ã€ãåŸ
ã®é žçŽ å©çšã«ã€ããŠã®ç 究ããã®å®éšçç¥èŠããŸ
ãšããŠç€ºããã®ã§ãããåå³ã¯ååæ§ã«åæããŒ
ã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬åå°å ¥åã®ãŠãµã®ç¶²
èã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬åå°å ¥åŸ15
ååŸã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯æ³šå°åŸ55å
åŸã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯åºè¡éå§åã®
ãŠãµã®ç¶²èã®ããŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬å
æ²»çãªãã®åºè¡éå§ããïŒæ¥ç®ã®ãŠãµã®ç¶²èã®ã
ãŒã©ãã°ã©ã ã瀺ããNo.ïŒã¯è¬åæ²»çã«ããå€æ§
ãããåºè¡éå§ããã®ãŠãµã®ç¶²èã®ããŒã©ãã°ã©
ã ã瀺ãã å€ãã®ç 究ããã®ç¥èŠã¯ãã¬ãŒã¶ãŒååºã¯ç¶²è
ã«ãããé žçŽ å©çšãæå·ããã¬ãŒã¶ãŒååºåŸã®ïŒ
æ¥ç®ã®é žçŽ å©çšé床ã1.0ãã0.17ã«äœäžãã
ïŒå¯Ÿç §ã«æ¯èŒããŠïŒåã®æžå°ïŒãé žçŽ æ倱ã¯70ïŒ ã«
éããããšã瀺ããŠãããã¬ãŒã¶ãŒååºããïŒâ
ïŒæ¥ç®ã«ç¶²èé žçŽ å©çšã¯æ£åžžã«æ»ãããšãèªãã
ããïŒçµæãè¡šïŒã«ç€ºãïŒã
ãè¡šã
æ¬çºæã®è¬åã¯ã¬ãŒã¶ãŒååºåŸã®å埩çå€å
ïŒé žçŽ å©çšã®æ£åžžåïŒã®é床ãäžæãããã®ã«è²Ž
éã§ããããšãèŠåºãããã åŸã€ãŠãæ¬çºæã®è¬åã¯ç¶²èé žçŽ ä»å åã³çäœ
é»æ°æŽ»æ§ã«å®è³ªç圱é¿ãåãŒããã¬ãŒã¶ãŒååºã«
察ãã網èå¿çã軜æžãã網èæ©èœãåºæããã
ãšãæãããšãªãã æ¬çºæã®è¬åã次ã®ç®çãæããèšåºè©Šéšã«ä»
ããïŒ ïŒ æ°è©Šè¬ã®å¹çã®èšåºçè©äŸ¡ã ïŒ çŒç§ã«ãããŠäœ¿çšãããŠãããã®ä»ã®è©Šè¬ãš
æ¯èŒããŠã®æ²»ççå¹çã®è©äŸ¡ã æ¬çºæã®è¬åã¯æ¬¡ã®ç æ ã®æ²»çã«äœ¿çšãããïŒ ïŒ äžå¿è絡網èãžã¹ãããã€ãŒïŒ ïœ äžå¿è絡網èãžã¹ãããã€ãŒã®ä¹Ÿç¥æ ïœ äžå¿è絡網èãžã¹ãããã€ãŒã®ã«ãã¿åºã
åºè¡æã ïŒ äžå¿ç¶²èéèåã³ãã®æ¯èã®è¡æ çïŒ ïœ åŸâè¡æ 網èåºè¡ ïœ äžå¿çŒåºã«ãããè質æ²ç©ã ïŒ åçš®è管ç å ã®çŒçåºè¡ïŒ ïœ ç³å°¿ç ã ïœ è管çã ïœ è¡ç®¡æ°çã䌎ãè¡æ çã ïœ äžå¿è絡網èãžã¹ãããã€ãŒã ïŒ è¿èŠæ§è絡網èãžã¹ãããã€ãŒïŒ ïœ ä¹Ÿç¥æã ïœ åºè¡æã ïœ ããã¯ã¹ç¹ïŒFuxâ²s spotïŒã ïŒ äžå¿å£æ¿â網èã¢ããªãããã€ãŒã ïŒ æ¥å åã³ã¬ãŒã¶ãŒèªçºç¶²èç«å·ã ïŒ ç¡åäœè絡網èãžã¹ãããã€ãŒïŒ ïœ è¥å¹Žæ§ïŒžâæè²äœç¶²èåé¢çã ïœ ãžã¹ãããã€ãŒè¿èŠç¶²èåé¢çã æ¬çºæã®è¬åã®èšåºè©Šéšãå šãŠæ ¢æ§çç¶ã®åŸŽå
ãæããå šéšã§453åã®ç®ãæãã380人ã®æ£è ã«
ã€ããŠè¡ã€ããæ¬çºæã®è¬åãçšããæ²»çãéå§
ããåã«æ£è ã«ã¯ãžã·ãã³ãããã·ãŠãŒã ãåçš®
åžåä¿é²æè¬ãçèå ã«æ³šå°ããããªããŒãŒåã³
ã±ã¢ããªãã·ã³ããã€ããªããªãžã³ãçµèäžã«æ
äžããããã€ã³ã·ã ãªã©ã®è©Šè¬ãçšããè¡ç®¡ä¿è·
å€åŠæ¹ãåã³ç¶²èåã³ç¡åäœåºè¡ã®åžåãäžå¿çŒ
åºã«ãžã¹ãããã€ãŒæ§å€åã䌎ãæç¶çã«äœãèŠ
åã«é¢ããŠæå¹ã§ãªãããšãå€æããç©çæ²»çã
äžããã æ¬çºæã®è¬åãçšããèšåºçµéšã¯ã網èåã³ç¡
åäœã«äœçœ®ããåºè¡ã®åžåãä¿é²ããå¹çã瀺ã
ãããã®è¬åã¯ãåçš®è管ç å ãäŸãã°ãç¡åäœ
åºè¡ãäžå¿ç¶²èéèåã³ãã®æ¯èã«ãããè¡æ ç
ã®äºæ¥æ§æãè¿èŠé¢é£åºè¡ãäžå¿è絡網èãžã¹ã
ããã€ãŒã®æ»²åºâåºè¡æãªã©ã®ç®ã®ç¶æ ã«äœ¿çšã
ãããæ¬çºæã®è¬åã®å¹èœã¯ãè絡網èãžã¹ãã
ãã€ãŒã®ä¹Ÿç¥æåã³è¿èŠè絡èçã®ä¹Ÿç¥æãè¥å¹Ž
æ§ïŒžâæè²äœåã³ãžã¹ãããã€ãŒæ§ç¶²èå¥é¢ç䞊
ã³ã«èŠåæ©èœãæ¹è¯ããããã®ãžã¹ãããã€ãŒæ§
網èå¥é¢ã®æè¡åŸã®éã€ãæè¡åŸæéïŒïŒã1.5
幎ïŒã«ãããŠè©äŸ¡ããããæ¬çºæã®è¬åã¯æ¥å ç §
å°ã¬ãŒã¶ãŒè£ 眮æè¡ã«äŒŽã網èç«å·ã®æ²»çã«äœ¿çš
ããããèšåºè©Šéšããã®çµæã¯ãæç®ã«ã®ããã
ãŠããèŠåãèŠéã®æ€çŒé¡çç¹åŸŽïŒç¶²èåºè¡åã³
æèŠäžç®å¥é¢ã®çšåºŠã®æžå°ïŒãé»æ°ççåŠçç¥èŠ
ã«é¢é£ããäžçµã®äž»èŠ³çåã³å®èŠ³çæšæºã«åŸã€ãŠ
è©äŸ¡ããããã«ãªã¬ãã»ã€ã³è¡ç®¡é 圱åã³çŒåºå
çã幟ã€ãã®çäŸã«ãããŠè¡ããããæ€çŒé¡æ€æ»
ãèŠåã®å¢å€§ã䌎ã€ãéœæ§ã®å€åãéŠå°Ÿäžè²«ããŠ
瀺ããå Žåã«æ¹è¯ããããã®ãšãããããããèŠ
ååã³èŠéã«äœçã®å¢å€§ãèªããããªãå Žåã¯ã
ãã®å¿çã¯æ¹è¯ãšè©äŸ¡ããããšãã§ããªãã€ãã ã¯ãŒã³ãâãŠããŠã¹ïŒKuhntâUniusïŒãžã¹ã
ããã€ãŒã¯ã幎什40ã80æã®æ£è ã«ãããŠå ±éã
ãŠäž¡çŒã®çç¶ã®åŸŽåã瀺ãäžå¿è絡網èãžã¹ãã
ãã€ãŒã®çŸ€ã瀺ããã10.3ïŒ ã®æ£è ã¯é«è¡å§ã«ã
ããã58.3ïŒ ã®é«è¡å§ã¯ã¢ãããŒã 硬åçãè€å
ããŠããã14.6ïŒ ã¯äžè¬åã¢ãããŒã 硬åçãå
ãããè¬åãåçš®ç å ã®äžå¿è絡網èãžã¹ããã
ã€ãŒãæãã175çŒã«äœ¿çšãããèšåºè©Šéšã®ãã
ã«æ£è ãïŒçŸ€ã«åå²ããã第ïŒã®çŸ€ã¯ãè²çŽ äžç®
ã®æ¬ é¥æãã¯å±åšåè²çŽ äžç®å¥é¢ãšããŠç€ºããã
äžå¿è絡網èãžã¹ãããã€ãŒã®ä¹Ÿç¥æãæããç®
ã«ããæ§æãããã第ïŒçŸ€ã¯è¡æž æ§ã®æèŠäžç®å¥
é¢å³ã¡è¡æž âåºè¡æèŠäžç®å¥é¢å³ã¡Kuhntâ
Uniusãžã¹ãããã€ãŒã®æ»²åºâåºè¡æã瀺ãç®ã
ãæ§æããããè¡šïŒã¯äžå¿è絡網èãžã¹ãããã€
ãŒã®ä¹Ÿç¥æã«ãããŠæ¬çºæã®è¬åã䜿çšããæ²»ç
ããåŸãããç¥èŠã瀺ãã
ïŒé žçŽ å©çšã®æ£åžžåïŒã®é床ãäžæãããã®ã«è²Ž
éã§ããããšãèŠåºãããã åŸã€ãŠãæ¬çºæã®è¬åã¯ç¶²èé žçŽ ä»å åã³çäœ
é»æ°æŽ»æ§ã«å®è³ªç圱é¿ãåãŒããã¬ãŒã¶ãŒååºã«
察ãã網èå¿çã軜æžãã網èæ©èœãåºæããã
ãšãæãããšãªãã æ¬çºæã®è¬åã次ã®ç®çãæããèšåºè©Šéšã«ä»
ããïŒ ïŒ æ°è©Šè¬ã®å¹çã®èšåºçè©äŸ¡ã ïŒ çŒç§ã«ãããŠäœ¿çšãããŠãããã®ä»ã®è©Šè¬ãš
æ¯èŒããŠã®æ²»ççå¹çã®è©äŸ¡ã æ¬çºæã®è¬åã¯æ¬¡ã®ç æ ã®æ²»çã«äœ¿çšãããïŒ ïŒ äžå¿è絡網èãžã¹ãããã€ãŒïŒ ïœ äžå¿è絡網èãžã¹ãããã€ãŒã®ä¹Ÿç¥æ ïœ äžå¿è絡網èãžã¹ãããã€ãŒã®ã«ãã¿åºã
åºè¡æã ïŒ äžå¿ç¶²èéèåã³ãã®æ¯èã®è¡æ çïŒ ïœ åŸâè¡æ 網èåºè¡ ïœ äžå¿çŒåºã«ãããè質æ²ç©ã ïŒ åçš®è管ç å ã®çŒçåºè¡ïŒ ïœ ç³å°¿ç ã ïœ è管çã ïœ è¡ç®¡æ°çã䌎ãè¡æ çã ïœ äžå¿è絡網èãžã¹ãããã€ãŒã ïŒ è¿èŠæ§è絡網èãžã¹ãããã€ãŒïŒ ïœ ä¹Ÿç¥æã ïœ åºè¡æã ïœ ããã¯ã¹ç¹ïŒFuxâ²s spotïŒã ïŒ äžå¿å£æ¿â網èã¢ããªãããã€ãŒã ïŒ æ¥å åã³ã¬ãŒã¶ãŒèªçºç¶²èç«å·ã ïŒ ç¡åäœè絡網èãžã¹ãããã€ãŒïŒ ïœ è¥å¹Žæ§ïŒžâæè²äœç¶²èåé¢çã ïœ ãžã¹ãããã€ãŒè¿èŠç¶²èåé¢çã æ¬çºæã®è¬åã®èšåºè©Šéšãå šãŠæ ¢æ§çç¶ã®åŸŽå
ãæããå šéšã§453åã®ç®ãæãã380人ã®æ£è ã«
ã€ããŠè¡ã€ããæ¬çºæã®è¬åãçšããæ²»çãéå§
ããåã«æ£è ã«ã¯ãžã·ãã³ãããã·ãŠãŒã ãåçš®
åžåä¿é²æè¬ãçèå ã«æ³šå°ããããªããŒãŒåã³
ã±ã¢ããªãã·ã³ããã€ããªããªãžã³ãçµèäžã«æ
äžããããã€ã³ã·ã ãªã©ã®è©Šè¬ãçšããè¡ç®¡ä¿è·
å€åŠæ¹ãåã³ç¶²èåã³ç¡åäœåºè¡ã®åžåãäžå¿çŒ
åºã«ãžã¹ãããã€ãŒæ§å€åã䌎ãæç¶çã«äœãèŠ
åã«é¢ããŠæå¹ã§ãªãããšãå€æããç©çæ²»çã
äžããã æ¬çºæã®è¬åãçšããèšåºçµéšã¯ã網èåã³ç¡
åäœã«äœçœ®ããåºè¡ã®åžåãä¿é²ããå¹çã瀺ã
ãããã®è¬åã¯ãåçš®è管ç å ãäŸãã°ãç¡åäœ
åºè¡ãäžå¿ç¶²èéèåã³ãã®æ¯èã«ãããè¡æ ç
ã®äºæ¥æ§æãè¿èŠé¢é£åºè¡ãäžå¿è絡網èãžã¹ã
ããã€ãŒã®æ»²åºâåºè¡æãªã©ã®ç®ã®ç¶æ ã«äœ¿çšã
ãããæ¬çºæã®è¬åã®å¹èœã¯ãè絡網èãžã¹ãã
ãã€ãŒã®ä¹Ÿç¥æåã³è¿èŠè絡èçã®ä¹Ÿç¥æãè¥å¹Ž
æ§ïŒžâæè²äœåã³ãžã¹ãããã€ãŒæ§ç¶²èå¥é¢ç䞊
ã³ã«èŠåæ©èœãæ¹è¯ããããã®ãžã¹ãããã€ãŒæ§
網èå¥é¢ã®æè¡åŸã®éã€ãæè¡åŸæéïŒïŒã1.5
幎ïŒã«ãããŠè©äŸ¡ããããæ¬çºæã®è¬åã¯æ¥å ç §
å°ã¬ãŒã¶ãŒè£ 眮æè¡ã«äŒŽã網èç«å·ã®æ²»çã«äœ¿çš
ããããèšåºè©Šéšããã®çµæã¯ãæç®ã«ã®ããã
ãŠããèŠåãèŠéã®æ€çŒé¡çç¹åŸŽïŒç¶²èåºè¡åã³
æèŠäžç®å¥é¢ã®çšåºŠã®æžå°ïŒãé»æ°ççåŠçç¥èŠ
ã«é¢é£ããäžçµã®äž»èŠ³çåã³å®èŠ³çæšæºã«åŸã€ãŠ
è©äŸ¡ããããã«ãªã¬ãã»ã€ã³è¡ç®¡é 圱åã³çŒåºå
çã幟ã€ãã®çäŸã«ãããŠè¡ããããæ€çŒé¡æ€æ»
ãèŠåã®å¢å€§ã䌎ã€ãéœæ§ã®å€åãéŠå°Ÿäžè²«ããŠ
瀺ããå Žåã«æ¹è¯ããããã®ãšãããããããèŠ
ååã³èŠéã«äœçã®å¢å€§ãèªããããªãå Žåã¯ã
ãã®å¿çã¯æ¹è¯ãšè©äŸ¡ããããšãã§ããªãã€ãã ã¯ãŒã³ãâãŠããŠã¹ïŒKuhntâUniusïŒãžã¹ã
ããã€ãŒã¯ã幎什40ã80æã®æ£è ã«ãããŠå ±éã
ãŠäž¡çŒã®çç¶ã®åŸŽåã瀺ãäžå¿è絡網èãžã¹ãã
ãã€ãŒã®çŸ€ã瀺ããã10.3ïŒ ã®æ£è ã¯é«è¡å§ã«ã
ããã58.3ïŒ ã®é«è¡å§ã¯ã¢ãããŒã 硬åçãè€å
ããŠããã14.6ïŒ ã¯äžè¬åã¢ãããŒã 硬åçãå
ãããè¬åãåçš®ç å ã®äžå¿è絡網èãžã¹ããã
ã€ãŒãæãã175çŒã«äœ¿çšãããèšåºè©Šéšã®ãã
ã«æ£è ãïŒçŸ€ã«åå²ããã第ïŒã®çŸ€ã¯ãè²çŽ äžç®
ã®æ¬ é¥æãã¯å±åšåè²çŽ äžç®å¥é¢ãšããŠç€ºããã
äžå¿è絡網èãžã¹ãããã€ãŒã®ä¹Ÿç¥æãæããç®
ã«ããæ§æãããã第ïŒçŸ€ã¯è¡æž æ§ã®æèŠäžç®å¥
é¢å³ã¡è¡æž âåºè¡æèŠäžç®å¥é¢å³ã¡Kuhntâ
Uniusãžã¹ãããã€ãŒã®æ»²åºâåºè¡æã瀺ãç®ã
ãæ§æããããè¡šïŒã¯äžå¿è絡網èãžã¹ãããã€
ãŒã®ä¹Ÿç¥æã«ãããŠæ¬çºæã®è¬åã䜿çšããæ²»ç
ããåŸãããç¥èŠã瀺ãã
ãè¡šã
ãã®æ®µéã®ç
æ°ã®èšåºåçã¯äœçã®å€åã瀺ã
ãªãã€ãã0.2ã0.3ã®èŠåã®å¢å€§ã36.4ïŒ ããã
ãšã¯ãã®æ®µéã®ç æ°ã«ãããæ¬çºæã®è¬åã®å¹ç
ãç«èšŒãããã®ã§ããããã¬ã³ã¿ã«ãçšããŠåæ§
ã«67人ã®æ£è ã«çŒçåŸæ¹æ³šå°ã®åœ¢æ ã§æäžããåº
ç¯å²ã®èšåºçµéšã§ã¯èŠåã®0.3ã®å¢å€§ããããã
ãäŸã¯ïŒäŸããªãã€ããæ¬çºæã®è¬åãçšããæ²»
çååã³æ²»çåŸã«40人ã®æ£è ã«ã€ããŠè¡ã€ãé»æ°
ççåŠçè©Šéšã¯ç¶²èæ©èœã«é¢ããŠå®è³ªçãªæ¹è¯ã
瀺ããã äžå¿è絡網èãžã¹ãããã€ãŒã®æ»²åºâåºè¡æã
æãã第ïŒã®çŸ€ã«ãããŠã¯ãæ¬çºæã®è¬åãå šéš
ã§153ã®ç®ã«äžãããå šãŠã®æ£è ã¯äºããã¢ã³ã®
ãã³åã³ãã¯ã¬ãã³ã®ãããªè©Šè¬ã§çµå£çã«å±éš
çã«ãåã³çµèäžæãã¯çŒçåŸæ¹æ³šå°ãšããŠãžã·
ãã³æãã¯ãžã·ãã³ãšãããµãœã³ã®çµåãïŒåäž
泚å°åšå ã«ã12.5ïŒ ãžã·ãã³ã®0.3ã0.5mlæäžéã
0.1ã0.2mlæäžéã®750åäœãããµãœã³ïŒ0.3ã0.5
mlæäžéã®12.5ïŒ ãžã·ãã³æº¶æ¶²ïŒã®ãããªè©Šè¬ã§
æ²»çãããŠããããã®æ²»çã¯æèŠäžç®å¥é¢æãã¯
滲åºâåºè¡æèŠäžç®å¥é¢ã®çšåºŠã«ãã圱é¿ãåãŒ
ããªãã€ããè¡šïŒã¯äžå¿è絡網èãžã¹ãããã€ãŒ
ã®æ»²åºâåºè¡æã«ãããæ¬çºæã®è¬åã䜿çšãã
çµæãšãããµãœã³åã³ãžã·ãã³ã®çµåãã®çµæã
察æ¯ããŠç€ºããã®ã§ããã
ãªãã€ãã0.2ã0.3ã®èŠåã®å¢å€§ã36.4ïŒ ããã
ãšã¯ãã®æ®µéã®ç æ°ã«ãããæ¬çºæã®è¬åã®å¹ç
ãç«èšŒãããã®ã§ããããã¬ã³ã¿ã«ãçšããŠåæ§
ã«67人ã®æ£è ã«çŒçåŸæ¹æ³šå°ã®åœ¢æ ã§æäžããåº
ç¯å²ã®èšåºçµéšã§ã¯èŠåã®0.3ã®å¢å€§ããããã
ãäŸã¯ïŒäŸããªãã€ããæ¬çºæã®è¬åãçšããæ²»
çååã³æ²»çåŸã«40人ã®æ£è ã«ã€ããŠè¡ã€ãé»æ°
ççåŠçè©Šéšã¯ç¶²èæ©èœã«é¢ããŠå®è³ªçãªæ¹è¯ã
瀺ããã äžå¿è絡網èãžã¹ãããã€ãŒã®æ»²åºâåºè¡æã
æãã第ïŒã®çŸ€ã«ãããŠã¯ãæ¬çºæã®è¬åãå šéš
ã§153ã®ç®ã«äžãããå šãŠã®æ£è ã¯äºããã¢ã³ã®
ãã³åã³ãã¯ã¬ãã³ã®ãããªè©Šè¬ã§çµå£çã«å±éš
çã«ãåã³çµèäžæãã¯çŒçåŸæ¹æ³šå°ãšããŠãžã·
ãã³æãã¯ãžã·ãã³ãšãããµãœã³ã®çµåãïŒåäž
泚å°åšå ã«ã12.5ïŒ ãžã·ãã³ã®0.3ã0.5mlæäžéã
0.1ã0.2mlæäžéã®750åäœãããµãœã³ïŒ0.3ã0.5
mlæäžéã®12.5ïŒ ãžã·ãã³æº¶æ¶²ïŒã®ãããªè©Šè¬ã§
æ²»çãããŠããããã®æ²»çã¯æèŠäžç®å¥é¢æãã¯
滲åºâåºè¡æèŠäžç®å¥é¢ã®çšåºŠã«ãã圱é¿ãåãŒ
ããªãã€ããè¡šïŒã¯äžå¿è絡網èãžã¹ãããã€ãŒ
ã®æ»²åºâåºè¡æã«ãããæ¬çºæã®è¬åã䜿çšãã
çµæãšãããµãœã³åã³ãžã·ãã³ã®çµåãã®çµæã
察æ¯ããŠç€ºããã®ã§ããã
ãè¡šã
çŒçåŸæ¹æ³šå°ã®åŸ153ã®ç®ã®ãã¡123ã¯çŒåºã«å¥œ
ãŸããå€åãšå¹³å0.08ã0.1ã®èŠåã®å¢å ããã€
ãŠå¿çããã®ã«å¯Ÿãããããµãœã³åã³ãžã·ãã³çµ
åãåŠæ¹ã«åŸã€ã察å¿ããå¹³åã®èŠåã®å¢å ã¯
0.03ã§ãã€ãã è¡šïŒã¯äžå¿è絡網èãžã¹ãããã€ãŒã®æ»²åºâåº
è¡æãæããæ£è ã®é»æ°ççåŠçè©Šéšããã®ç¥èŠ
ã§ãããè¡šïŒããèŠãããããã«ãïœåã³ïœã®
ERGæ³¢ã®æ¯å¹ ã¯æ¬çºæã®è¬åã®æäžã«å¿çããŠ
åæå€ããããããã38ïŒ åã³24ïŒ äžæããã
ãŸããå€åãšå¹³å0.08ã0.1ã®èŠåã®å¢å ããã€
ãŠå¿çããã®ã«å¯Ÿãããããµãœã³åã³ãžã·ãã³çµ
åãåŠæ¹ã«åŸã€ã察å¿ããå¹³åã®èŠåã®å¢å ã¯
0.03ã§ãã€ãã è¡šïŒã¯äžå¿è絡網èãžã¹ãããã€ãŒã®æ»²åºâåº
è¡æãæããæ£è ã®é»æ°ççåŠçè©Šéšããã®ç¥èŠ
ã§ãããè¡šïŒããèŠãããããã«ãïœåã³ïœã®
ERGæ³¢ã®æ¯å¹ ã¯æ¬çºæã®è¬åã®æäžã«å¿çããŠ
åæå€ããããããã38ïŒ åã³24ïŒ äžæããã
ãè¡šã
æ¬çºæã®è¬åãçšããæ²»çã®çµæãæèŠäžç®å¥
é¢ãçž®å°ãã81.5ïŒ ã®æ£è ã«ãããŠèŠåãå¢å€§ã
ãããã®æ§ãªèŠåã®å¢å€§ã¯ãã®éãäžå¿çŒåºã®æ
å·ã«ãããæ¬çºæã®è¬åã®é«ãå¹èœã瀺ããã®ã§
ãããæ¬çºæã®è¬åããããµãœã³ãšãžã·ãã³ã®çµ
åããšå¯Ÿæ¯ããŠæ¯èŒå¹èœåæãè¡ã€ãçµæããã
ãµãœã³ãšãžã·ãã³ã®çµåãè¬åæ²»çã¯48.8ïŒ ã®éœ
æ§å¿ççãåŒãåºããã®ã«ãããªãã€ãã®ã§åè
ã®æ¹ãã¯ããã«åªããŠããã次ã«äžå¿è絡網èãž
ã¹ãããã€ãŒã®èšºæãããç¢çæãæãã83æã®
æ£è ã®çäŸå±¥æŽããã®æç²ãäŸç€ºãããæ²»çé
å§åã«å³ç®ã®èŠåã¯æåå®å¯èœè·é¢ãæ£è ã®é¡ã
ã40cmã§ãããå·Šç®ãæåå®å¯èœè·é¢ãé¡ãã20
cmã§ãã€ããæ²»çïŒæ¬çºæã®è¬åã®ïŒïŒ 溶液ã®
0.5mlæäžéãçŒçåŸæ¹ããæäžNo.15ïŒåŸã«å³ç®
ã®èŠåã¯0.03ã«ãå·Šç®ã¯0.02ã«äžæãããå¿çã®
ç¶ç¶ã¯ïŒã±æéèšé²ãããããã®åŸã«èŠåã¯å ã®
æ°Žæºã«æ»ã€ãŠããŸã€ãããã¬ã³ã¿ã«ïŒ0.5mlãNo.
15ãçŒçåŸæ¹ããæäžïŒãçšãã泚å°ã®æ²»çã¯ç®
ã§èŠåããããå¿çããããããªãã€ãã æ¬çºæã®è¬åãçšããæ²»çãç¹°è¿ãè¡ããšïŒïŒ
ïŒ ã®è¬å溶液0.5mlã®æäžéãçŒçåŸæ¹ããæäžã
No.15ïŒå³ç®ã§0.01ãå·Šç®ã§0.03ã®èŠåã®å¢å€§ãåŸ
ãããã åŸã€ãŠãäžå¿è絡網èãžã¹ãããã€ãŒã®ç¢çæ
ã«ãããæ¬çºæã®è¬åã®æ²»çã«ããæ®åèŠåã®å¢
倧ã¯ã網è代è¬éçšã«åãŒãæçãªå¹æã«é¢ãã
å®éšçç¥èŠãå®èšŒãããã®ã§ããã æ¬çºæã®è¬åã網èåºè¡åã³äžå¿çŒåºã«ããã
äºæ¬¡çè質æ²ç©ã®æ²»çã«ãããŠåã³ç æ°ã®éå§ã
ã1.5ã±æ以äžã®äºæ¥æ§æã«ãããäžå¿ç¶²èéè
åã³ãã®æ¯èãå«ãè¡æ çã®åŸŽåãæãã138ã®
ç®ã«äœ¿çšãããç æ°ã®äºæ¥æ§æã«ãããŠæ£è ã¯é
åžžè¡ç®¡ä¿è·å€ãçé žè±æ°Žé µçŽ èªå°è¬åããããªã³
ãšãããµãœã³ãçµåããçŒçåŸæ¹ã®æ³šå°ããã€ã
ãªããªãžã³ã®çµèäžæ³šå°ãäžããããããã®æ²»ç
ã¯ãå®å šã«è¡æ çç¶æ ãå転ããããšãã§ããã
åŒãç¶ãã¬ãŒã¶ãŒååºãäžå¯èœã«ãã倧ããªç¶²è
åºè¡ã®é åãæ®ãããè¡šïŒã«æ¬çºæã®è¬åããžã·
ãã³ããããªã³ãšãããµãœã³ãšã®çµåããåŸâè¡
æ ç網èåºè¡ã®æ²»çã«çšããçµæãæ²ããã
é¢ãçž®å°ãã81.5ïŒ ã®æ£è ã«ãããŠèŠåãå¢å€§ã
ãããã®æ§ãªèŠåã®å¢å€§ã¯ãã®éãäžå¿çŒåºã®æ
å·ã«ãããæ¬çºæã®è¬åã®é«ãå¹èœã瀺ããã®ã§
ãããæ¬çºæã®è¬åããããµãœã³ãšãžã·ãã³ã®çµ
åããšå¯Ÿæ¯ããŠæ¯èŒå¹èœåæãè¡ã€ãçµæããã
ãµãœã³ãšãžã·ãã³ã®çµåãè¬åæ²»çã¯48.8ïŒ ã®éœ
æ§å¿ççãåŒãåºããã®ã«ãããªãã€ãã®ã§åè
ã®æ¹ãã¯ããã«åªããŠããã次ã«äžå¿è絡網èãž
ã¹ãããã€ãŒã®èšºæãããç¢çæãæãã83æã®
æ£è ã®çäŸå±¥æŽããã®æç²ãäŸç€ºãããæ²»çé
å§åã«å³ç®ã®èŠåã¯æåå®å¯èœè·é¢ãæ£è ã®é¡ã
ã40cmã§ãããå·Šç®ãæåå®å¯èœè·é¢ãé¡ãã20
cmã§ãã€ããæ²»çïŒæ¬çºæã®è¬åã®ïŒïŒ 溶液ã®
0.5mlæäžéãçŒçåŸæ¹ããæäžNo.15ïŒåŸã«å³ç®
ã®èŠåã¯0.03ã«ãå·Šç®ã¯0.02ã«äžæãããå¿çã®
ç¶ç¶ã¯ïŒã±æéèšé²ãããããã®åŸã«èŠåã¯å ã®
æ°Žæºã«æ»ã€ãŠããŸã€ãããã¬ã³ã¿ã«ïŒ0.5mlãNo.
15ãçŒçåŸæ¹ããæäžïŒãçšãã泚å°ã®æ²»çã¯ç®
ã§èŠåããããå¿çããããããªãã€ãã æ¬çºæã®è¬åãçšããæ²»çãç¹°è¿ãè¡ããšïŒïŒ
ïŒ ã®è¬å溶液0.5mlã®æäžéãçŒçåŸæ¹ããæäžã
No.15ïŒå³ç®ã§0.01ãå·Šç®ã§0.03ã®èŠåã®å¢å€§ãåŸ
ãããã åŸã€ãŠãäžå¿è絡網èãžã¹ãããã€ãŒã®ç¢çæ
ã«ãããæ¬çºæã®è¬åã®æ²»çã«ããæ®åèŠåã®å¢
倧ã¯ã網è代è¬éçšã«åãŒãæçãªå¹æã«é¢ãã
å®éšçç¥èŠãå®èšŒãããã®ã§ããã æ¬çºæã®è¬åã網èåºè¡åã³äžå¿çŒåºã«ããã
äºæ¬¡çè質æ²ç©ã®æ²»çã«ãããŠåã³ç æ°ã®éå§ã
ã1.5ã±æ以äžã®äºæ¥æ§æã«ãããäžå¿ç¶²èéè
åã³ãã®æ¯èãå«ãè¡æ çã®åŸŽåãæãã138ã®
ç®ã«äœ¿çšãããç æ°ã®äºæ¥æ§æã«ãããŠæ£è ã¯é
åžžè¡ç®¡ä¿è·å€ãçé žè±æ°Žé µçŽ èªå°è¬åããããªã³
ãšãããµãœã³ãçµåããçŒçåŸæ¹ã®æ³šå°ããã€ã
ãªããªãžã³ã®çµèäžæ³šå°ãäžããããããã®æ²»ç
ã¯ãå®å šã«è¡æ çç¶æ ãå転ããããšãã§ããã
åŒãç¶ãã¬ãŒã¶ãŒååºãäžå¯èœã«ãã倧ããªç¶²è
åºè¡ã®é åãæ®ãããè¡šïŒã«æ¬çºæã®è¬åããžã·
ãã³ããããªã³ãšãããµãœã³ãšã®çµåããåŸâè¡
æ ç網èåºè¡ã®æ²»çã«çšããçµæãæ²ããã
ãè¡šã
æ¬çºæã®è¬åãçšããæ²»çã«åŸã€ãŠïŒçŒçåŸæ¹
ããæäžãïŒïŒ è¬å溶液0.5mlã®æäžéãNo.15ïŒ
101åã®ç®ïŒ73.1ïŒ ïŒã«èŠåã®å¢å€§åã³ç¶²èåºè¡
ã®æžå°ãèšé²ãããã®ã«å¯Ÿãããžã·ãã³åã³ãã
ãªã³ãšãããµãœã³ãšã®çµåããçšããåŠæ¹ã¯åã
45.9ïŒ åã³30ïŒ ã®å¿ççãäžããã«ãããªãã€
ããæ¬çºæã®è¬åãçšããæ²»çã«åŸã€ãèŠåã«ã
ããå¹³åå¢å ã¯0.2ã§ãã€ãã®ã«å¯Ÿãããžã·ãã³
åã³ãããªã³ãšãããµãœã³ãšã®çµåãã«ãããã
ã®å€æ°ã¯åã 0.06åã³0.07ã§ãã€ãã è¡š10ã¯ãäžå¿ç¶²èéèã«åãŒãè¡æ çãæãã
æ£è ã«ããã網èã®æ©èœçè©äŸ¡ã®çµæã瀺ããå
è¡šãããããããã«ãæ¬çºæã®è¬åã«ããæ²»çã«
察å¿ããŠïœåã³bERGæ³¢ã®çžå¯Ÿæ¯å¹ ã¯å34ïŒ åã³
16ïŒ ïŒåºçºå€ãããé«ãïŒå¢å€§ããã
ããæäžãïŒïŒ è¬å溶液0.5mlã®æäžéãNo.15ïŒ
101åã®ç®ïŒ73.1ïŒ ïŒã«èŠåã®å¢å€§åã³ç¶²èåºè¡
ã®æžå°ãèšé²ãããã®ã«å¯Ÿãããžã·ãã³åã³ãã
ãªã³ãšãããµãœã³ãšã®çµåããçšããåŠæ¹ã¯åã
45.9ïŒ åã³30ïŒ ã®å¿ççãäžããã«ãããªãã€
ããæ¬çºæã®è¬åãçšããæ²»çã«åŸã€ãèŠåã«ã
ããå¹³åå¢å ã¯0.2ã§ãã€ãã®ã«å¯Ÿãããžã·ãã³
åã³ãããªã³ãšãããµãœã³ãšã®çµåãã«ãããã
ã®å€æ°ã¯åã 0.06åã³0.07ã§ãã€ãã è¡š10ã¯ãäžå¿ç¶²èéèã«åãŒãè¡æ çãæãã
æ£è ã«ããã網èã®æ©èœçè©äŸ¡ã®çµæã瀺ããå
è¡šãããããããã«ãæ¬çºæã®è¬åã«ããæ²»çã«
察å¿ããŠïœåã³bERGæ³¢ã®çžå¯Ÿæ¯å¹ ã¯å34ïŒ åã³
16ïŒ ïŒåºçºå€ãããé«ãïŒå¢å€§ããã
ãè¡šã
åŸã€ãŠãæ¬çºæã®è¬åã®ç 究ããã®èšåºçåã³
é»æ°ççåŠçç¥èŠã¯ãäžå¿ç¶²èéèåã³ãã®æ¯è
ããããè¡æ çã®äºæ¥æ§æã«ããããã®é«ãå¹èœ
ãäŸç€ºãããã®ã§ããã äžå¿ç¶²èéèã®è¡æ çãæãã10人ã®æ£è ã¯ã
èŠåã®æžå°ã®çŽæ¥ã®åå ã§ããäžå¿çŒåºã«ããã
å°éã®ç¡¬ã滲åºãç©è³ªïŒè質é¡ïŒãæããããšã
æ€çŒé¡æ€æ»ã«ãã瀺ããããæ¬çºæã®è¬åãçšã
ãæ²»çåŸãæ€çŒé¡æ€æ»ã¯äžå¿çŒåºã«ãããè質æ²
ç©ã®çšåºŠã®æžå°ã瀺ããåæã«èŠåãå¹³åã§0.2
å¢å€§ããããšã瀺ããããã®èšåºçç¥èŠã¯ãæ¬çº
æã®è¬åãè質代è¬ã«äžãã確蚌ãšãªããããèš
åºç 究ã¯ãæ¬çºæã®è¬åã®çŒçåºè¡ã®æ²»çã«ãã
ãé«ãå¹èœã確ç«ãããè¡š11ã¯æ¬çºæã®è¬åãçš
ãã70ã®ç®ã«ãããåçºæ§çŒçåºè¡ã®æ²»ççµæã§
ããã
é»æ°ççåŠçç¥èŠã¯ãäžå¿ç¶²èéèåã³ãã®æ¯è
ããããè¡æ çã®äºæ¥æ§æã«ããããã®é«ãå¹èœ
ãäŸç€ºãããã®ã§ããã äžå¿ç¶²èéèã®è¡æ çãæãã10人ã®æ£è ã¯ã
èŠåã®æžå°ã®çŽæ¥ã®åå ã§ããäžå¿çŒåºã«ããã
å°éã®ç¡¬ã滲åºãç©è³ªïŒè質é¡ïŒãæããããšã
æ€çŒé¡æ€æ»ã«ãã瀺ããããæ¬çºæã®è¬åãçšã
ãæ²»çåŸãæ€çŒé¡æ€æ»ã¯äžå¿çŒåºã«ãããè質æ²
ç©ã®çšåºŠã®æžå°ã瀺ããåæã«èŠåãå¹³åã§0.2
å¢å€§ããããšã瀺ããããã®èšåºçç¥èŠã¯ãæ¬çº
æã®è¬åãè質代è¬ã«äžãã確蚌ãšãªããããèš
åºç 究ã¯ãæ¬çºæã®è¬åã®çŒçåºè¡ã®æ²»çã«ãã
ãé«ãå¹èœã確ç«ãããè¡š11ã¯æ¬çºæã®è¬åãçš
ãã70ã®ç®ã«ãããåçºæ§çŒçåºè¡ã®æ²»ççµæã§
ããã
ãè¡šã
è¡š11ãããããããã«ãçŒçåºè¡ã¯ãçŒã®è管
æ§é ã®æ¿ããæå·å³ã¡ãç³å°¿ç網èçã®å¢æ®æã
ç¡åäœãžã®ã¢ã€ã«ã¹ç æãã¯è¥å¹Žæ§åºè¡ãååºã®
éã«åããªãã€ãäžå¿ç¶²èéèã®æ¯èããããè¡
æ çã«äºæ¬¡çãªç¶²èã®è管æ°çãªã©ãã掟çã
ãããã®çŸ€ã®æ£è ã®ç¡åäœåºè¡ã¯ãåçºããåŸå
ãæãããæ¬çºæã®è¬åã«ããæ²»çã®åã«æ£è ã¯
ãã€ãããªãžã³ãçµèäžæ³šå°ã«ããåãåãããž
ã·ãã³ãçŒçåŸæ¹ããæäžãããããã®æ²»çã¯èŠ
åã®å¢å€§ãåŒãåºããªãã€ããæ¬çºæã®è¬åã§æ²»
çãããåçºæ§çŒçåºè¡ãæãã85.7ïŒ ã®ç®ã«èŠ
ãããæ¹è¯ãããèšåºå€èŠ³ïŒçŒçåºè¡ã®éšååž
åïŒåã³èŠåã®å¢å€§ã¯ãç®ã®è管æ§é ããããã
ã®éãç çåŠã®åœ¢æ ã«ãããæ¬çºæã®è¬åã®é«ã
å¹æãå®èšŒãããã®ã§ããã ç³å°¿ç ã«åºã¥ãçŒçåºè¡ã«ãããŠèŠåã®å¹³åå¢
倧ã¯0.03ã0.2ãå€åãã0.06ã§ãã€ããäžå¿ç¶²è
éèã®æ¯èããããè¡æ çã«äºæ¬¡çã«çããåçº
ççŒçåºè¡ãæããæ£è ã«ãããèŠåã®å¢å€§ã¯å¹³
åã§0.2ã§ãã€ããè管çãæããæ£è ã®çŸ€ã«ã
ããŠèŠåã¯å¹³å0.12å¢å€§ããã®ã«å¯Ÿããäžå¿è管
網èãžã¹ãããã€ãŒãæãã矀ã«èšé²ãããŠãã
ããã¯0.23ã§ãã€ããè¡š12ã¯è管ç å ã®çŒçåºè¡
ã«ãããæ¬çºæã®è¬ååã³ãžã·ãã³ãçšããæ²»ç
çµæã§ããã
æ§é ã®æ¿ããæå·å³ã¡ãç³å°¿ç網èçã®å¢æ®æã
ç¡åäœãžã®ã¢ã€ã«ã¹ç æãã¯è¥å¹Žæ§åºè¡ãååºã®
éã«åããªãã€ãäžå¿ç¶²èéèã®æ¯èããããè¡
æ çã«äºæ¬¡çãªç¶²èã®è管æ°çãªã©ãã掟çã
ãããã®çŸ€ã®æ£è ã®ç¡åäœåºè¡ã¯ãåçºããåŸå
ãæãããæ¬çºæã®è¬åã«ããæ²»çã®åã«æ£è ã¯
ãã€ãããªãžã³ãçµèäžæ³šå°ã«ããåãåãããž
ã·ãã³ãçŒçåŸæ¹ããæäžãããããã®æ²»çã¯èŠ
åã®å¢å€§ãåŒãåºããªãã€ããæ¬çºæã®è¬åã§æ²»
çãããåçºæ§çŒçåºè¡ãæãã85.7ïŒ ã®ç®ã«èŠ
ãããæ¹è¯ãããèšåºå€èŠ³ïŒçŒçåºè¡ã®éšååž
åïŒåã³èŠåã®å¢å€§ã¯ãç®ã®è管æ§é ããããã
ã®éãç çåŠã®åœ¢æ ã«ãããæ¬çºæã®è¬åã®é«ã
å¹æãå®èšŒãããã®ã§ããã ç³å°¿ç ã«åºã¥ãçŒçåºè¡ã«ãããŠèŠåã®å¹³åå¢
倧ã¯0.03ã0.2ãå€åãã0.06ã§ãã€ããäžå¿ç¶²è
éèã®æ¯èããããè¡æ çã«äºæ¬¡çã«çããåçº
ççŒçåºè¡ãæããæ£è ã«ãããèŠåã®å¢å€§ã¯å¹³
åã§0.2ã§ãã€ããè管çãæããæ£è ã®çŸ€ã«ã
ããŠèŠåã¯å¹³å0.12å¢å€§ããã®ã«å¯Ÿããäžå¿è管
網èãžã¹ãããã€ãŒãæãã矀ã«èšé²ãããŠãã
ããã¯0.23ã§ãã€ããè¡š12ã¯è管ç å ã®çŒçåºè¡
ã«ãããæ¬çºæã®è¬ååã³ãžã·ãã³ãçšããæ²»ç
çµæã§ããã
ãè¡šã
ãžã·ãã³ã§æ²»çãããçŒçåºè¡ã«ãããèŠåã®
å¢å€§ã¯å¹³å0.02ã§ãã€ãã åŸã€ãŠãèšåºç 究ããåŸãããç¥èŠã¯ãæ¬çºæ
ã®è¬åãèšåºçŒç§ã«ãããŠåçš®è管ç å ã®çŒçåº
è¡ã«å¯Ÿæããããã«çšããããŠãããã®ä»ã®è©Šè¬
ãããåªããŠããããšã瀺ããã æ¬çºæã®è¬åã®å¹æããäžå¿çŒåºã«å¯Ÿããå±æ
çæå·ã®ããã«æžå°ããèŠåã䌎ãé«çšåºŠåã³äž
çšåºŠã®è¿èŠãæãã44ã®ç®ã«ãããèšåºè©Šéšã«ã
ããŠãæ€èšããã44ã®ç®ã®ãã¡20ã¯ãžã¹ãããã€
ãŒè¿äŒŒè¿èŠè絡èçã®ä¹Ÿç¥æã®åŸŽåãæãã22ã®
ç®ã«ãããŠã¯ç æ ã¯åºè¡æã«é²è¡ããŠããïŒãã®
ãã¡13ã¯Fuxç¹ãæããŠããïŒãæ¬çºæã®è¬åã¯
ãã®éãç æ°ã®æ£è 矀ã«ãããŠæ¥µããŠæå¹ã§ãã
ããšãå€æãããèšåºåçã«ãããäœçã®å€åã
䌎ããªãç æ°ã®ä¹Ÿç¥æã«ãããŠãèŠåã¯20ã®ç®ã®
ãã¡15ïŒ75ïŒ ïŒã«ãããŠãå¹³å0.2äžæããããšã
芳å¯ããããïŒäŸãæãããš52æã®æ£è ã¯åã©
ãã®ããããäž¡çŒã«é²è¡æ§è¿èŠãæããŠããïŒ18
ãžãªãããªïŒããã®æ£è ã¯ä»¥åã«é·å¹Žãã¿ãã³ã
ãšãã幎ã«ïŒåã®åºæºã§çµç¹æ²»çãèŠå³çã«ãã
è¿ãããæ¬çºæã®è¬åãçšããæ²»çïŒïŒïŒ ã®è¬å
溶液0.5mlæäžéã§çŒçåŸæ¹æäžãNo.15ïŒåŸãå³
ç®ã®èŠåã¯0.2ãã0.4ã«äžããå·Šç®ã®èŠåã¯0.1ã
ã0.4ã«äžã€ããé»æ°ççåŠçæ€æ»ã¯æ²»çåã¯æ®
ãã©èšé²ã§ããªãaERGæ³¢ã瀺ããã®ã«å¯Ÿããã
ã®å®äºåŸã¯æ¯å¹ ã¯25ã30ÎŒVã«äžæããæ²»çåã®
bERGæ³¢ã¯75ÎŒVã§ãã€ãã®ããæ²»çå®äºåŸã«ã¯
220ã225ÎŒVãšãªã€ãïŒå³ç®ïŒãå·Šç®ã«ããã
ERGã¯æ²»çåã®ïœæ³¢ã¯æ®ãã©èšé²ã§ãããæ²»ç
åŸã«ã¯ãã®æ¯å¹ ã¯12.5ÎŒVã«äžæããããšã瀺ã
ããbERGæ³¢ã¯æ²»çåã«ã¯100ÎŒVã§ãã€ãã®ãæ¬
çºæã®è¬åã§æ²»çå®äºåŸã«ã¯160ã175ÎŒVã«äžæ
ãããæ¬çºæã®è¬åã§ç¹°è¿ãæ²»çãç¶ãããšãèŠ
åãå³ç®ã§0.6ã0.8ãå·Šç®ã§0.6ã«å¢å€§ããã ç æ°ã®åºè¡æã«ãããŠãèšåºå€èŠ³ãåºè¡ã®éšå
åžååã³å¢å€§ããèŠåã«ãããŠéœæ§ã®ã·ããã22
ã®ç®ã®ãã¡10ã®ç®ã«ã€ããŠèŠããããïŒäŸãæã
ããšãé«åºŠã®è¿èŠãæ°ããªäžå¿çŒåºã«ãããæ°ã
ãªç¶²èåºè¡ãæãã35æã®æ£è ïŒã®ç¯æ£èŠåã¯äž¡
çŒã¯0.1ã§ãã€ããæ¬çºæã®è¬åãçšããæ²»ç
ïŒïŒïŒ è¬å溶液ã0.5mlã®æäžéã§çŒçåŸæ¹æäžã
No.15ïŒåŸã«ã¯ç¯æ£èŠåãå³ç®ã«ãããŠ0.2ã«å¢å€§
ããå·Šç®ã«ãããŠ0.4ã«å¢å€§ãã網èåºè¡ã®éšå
åžåããã€ãã åŸã€ãŠãæ¬çºæã®è¬åã¯ãè¿èŠæ§è絡網èãžã¹
ãããã€ãŒã䌎ãéãçŒåºç ã®çäŸã«ãããŠé«ã
æ²»çå¹æãæãããšçµè«ä»ããããšãã§ããã æ¬çºæã®è¬åã®èšåºè©Šéšãåã11人ã®æ£è ãã¹
ã¿ãŒãã«ãïŒStarhardtïŒç ã®åŸŽåã瀺ã22ã®ç®ã
ã«ã€ããŠè¡ã€ããè¡š13ã¯ã¹ã¿ãŒãã«ãç ã®æ²»çã«
å¿çããæ¬çºæã®è¬åã®èŠååã³èŠéã«åãŒã圱
é¿ã«é¢ããç¥èŠã瀺ãã
å¢å€§ã¯å¹³å0.02ã§ãã€ãã åŸã€ãŠãèšåºç 究ããåŸãããç¥èŠã¯ãæ¬çºæ
ã®è¬åãèšåºçŒç§ã«ãããŠåçš®è管ç å ã®çŒçåº
è¡ã«å¯Ÿæããããã«çšããããŠãããã®ä»ã®è©Šè¬
ãããåªããŠããããšã瀺ããã æ¬çºæã®è¬åã®å¹æããäžå¿çŒåºã«å¯Ÿããå±æ
çæå·ã®ããã«æžå°ããèŠåã䌎ãé«çšåºŠåã³äž
çšåºŠã®è¿èŠãæãã44ã®ç®ã«ãããèšåºè©Šéšã«ã
ããŠãæ€èšããã44ã®ç®ã®ãã¡20ã¯ãžã¹ãããã€
ãŒè¿äŒŒè¿èŠè絡èçã®ä¹Ÿç¥æã®åŸŽåãæãã22ã®
ç®ã«ãããŠã¯ç æ ã¯åºè¡æã«é²è¡ããŠããïŒãã®
ãã¡13ã¯Fuxç¹ãæããŠããïŒãæ¬çºæã®è¬åã¯
ãã®éãç æ°ã®æ£è 矀ã«ãããŠæ¥µããŠæå¹ã§ãã
ããšãå€æãããèšåºåçã«ãããäœçã®å€åã
䌎ããªãç æ°ã®ä¹Ÿç¥æã«ãããŠãèŠåã¯20ã®ç®ã®
ãã¡15ïŒ75ïŒ ïŒã«ãããŠãå¹³å0.2äžæããããšã
芳å¯ããããïŒäŸãæãããš52æã®æ£è ã¯åã©
ãã®ããããäž¡çŒã«é²è¡æ§è¿èŠãæããŠããïŒ18
ãžãªãããªïŒããã®æ£è ã¯ä»¥åã«é·å¹Žãã¿ãã³ã
ãšãã幎ã«ïŒåã®åºæºã§çµç¹æ²»çãèŠå³çã«ãã
è¿ãããæ¬çºæã®è¬åãçšããæ²»çïŒïŒïŒ ã®è¬å
溶液0.5mlæäžéã§çŒçåŸæ¹æäžãNo.15ïŒåŸãå³
ç®ã®èŠåã¯0.2ãã0.4ã«äžããå·Šç®ã®èŠåã¯0.1ã
ã0.4ã«äžã€ããé»æ°ççåŠçæ€æ»ã¯æ²»çåã¯æ®
ãã©èšé²ã§ããªãaERGæ³¢ã瀺ããã®ã«å¯Ÿããã
ã®å®äºåŸã¯æ¯å¹ ã¯25ã30ÎŒVã«äžæããæ²»çåã®
bERGæ³¢ã¯75ÎŒVã§ãã€ãã®ããæ²»çå®äºåŸã«ã¯
220ã225ÎŒVãšãªã€ãïŒå³ç®ïŒãå·Šç®ã«ããã
ERGã¯æ²»çåã®ïœæ³¢ã¯æ®ãã©èšé²ã§ãããæ²»ç
åŸã«ã¯ãã®æ¯å¹ ã¯12.5ÎŒVã«äžæããããšã瀺ã
ããbERGæ³¢ã¯æ²»çåã«ã¯100ÎŒVã§ãã€ãã®ãæ¬
çºæã®è¬åã§æ²»çå®äºåŸã«ã¯160ã175ÎŒVã«äžæ
ãããæ¬çºæã®è¬åã§ç¹°è¿ãæ²»çãç¶ãããšãèŠ
åãå³ç®ã§0.6ã0.8ãå·Šç®ã§0.6ã«å¢å€§ããã ç æ°ã®åºè¡æã«ãããŠãèšåºå€èŠ³ãåºè¡ã®éšå
åžååã³å¢å€§ããèŠåã«ãããŠéœæ§ã®ã·ããã22
ã®ç®ã®ãã¡10ã®ç®ã«ã€ããŠèŠããããïŒäŸãæã
ããšãé«åºŠã®è¿èŠãæ°ããªäžå¿çŒåºã«ãããæ°ã
ãªç¶²èåºè¡ãæãã35æã®æ£è ïŒã®ç¯æ£èŠåã¯äž¡
çŒã¯0.1ã§ãã€ããæ¬çºæã®è¬åãçšããæ²»ç
ïŒïŒïŒ è¬å溶液ã0.5mlã®æäžéã§çŒçåŸæ¹æäžã
No.15ïŒåŸã«ã¯ç¯æ£èŠåãå³ç®ã«ãããŠ0.2ã«å¢å€§
ããå·Šç®ã«ãããŠ0.4ã«å¢å€§ãã網èåºè¡ã®éšå
åžåããã€ãã åŸã€ãŠãæ¬çºæã®è¬åã¯ãè¿èŠæ§è絡網èãžã¹
ãããã€ãŒã䌎ãéãçŒåºç ã®çäŸã«ãããŠé«ã
æ²»çå¹æãæãããšçµè«ä»ããããšãã§ããã æ¬çºæã®è¬åã®èšåºè©Šéšãåã11人ã®æ£è ãã¹
ã¿ãŒãã«ãïŒStarhardtïŒç ã®åŸŽåã瀺ã22ã®ç®ã
ã«ã€ããŠè¡ã€ããè¡š13ã¯ã¹ã¿ãŒãã«ãç ã®æ²»çã«
å¿çããæ¬çºæã®è¬åã®èŠååã³èŠéã«åãŒã圱
é¿ã«é¢ããç¥èŠã瀺ãã
ãè¡šã
ãã®æ£è
矀ã«ãããŠè¡ãããæãææ矩ãªç¥èŠ
ã¯ã22ã®ç®ã®ãã¡20ã«ãããèŠåã®å¢å€§åã³æ²»ç
ã«æ®éæµæããâæã®ç æ°ã®20ã®ç®ã®ãã¡13
ã®ç®ã«ãããäžå¿æç¹ã®æžå°ã§ãã€ããã¹ã¿ãŒã
ã«ãç ã«ãããŠæ¬çºæã®è¬åãçšããåŠæ¹ã«ãã
æ²»çå¹æã®è©äŸ¡ãå ¬ç¥ã®è©Šè¬ãã©ãããŒã
ïŒflavinatïŒãšå¯Ÿæ¯ããŠæ€èšãããšãããåè ã®
æ¹ãããåªããŠããããšã瀺ãããã æ¬çºæã®è¬åãçšããæ²»çïŒïŒïŒ è¬å溶液ã
0.5mlæäžéã§çŒçåŸæ¹ããæäžãããNo.15ïŒãã
ä¿è·çŒé¡ãªãã§æ¥èã芳å¯ããçµææç¹é åã®å€ª
éœèªçºççãæããïŒäººã®æ£è ïŒïŒåã®ç®ïŒã«ã
ããŠéå§ãããæ£è ã¯16ã35æã§ãããå·ã®éå§
ããïŒãïŒã±æçµãŠãããå§èšç §äŒã«ãããäžå¹³
ã«ã¯ãèŠåãäœäžããããšåã³ãããããç®ã«ã
ãã10Ã10ãã®äžå¿æç¹ããã€ããèŠåã¯ïŒã€ã®
ç®ã«ãããŠã0.8ã«æžå°ããŠãããç 究æ£è ã®èŠ
éã¯äžå¿ã«äœçœ®ãã絶察æç¹ã瀺ãããæ¬çºæã®
è¬åãçšããæ²»çåŸãïŒã€ã®ç®ã®èŠåã¯0.8ãã
1.0ã«äžæããïŒã€ã®ç®ã¯0.5ãã0.6ã«äžæããã
å šãŠã®ç®ã«ãããŠçµ¶å¯Ÿæç¹é åã¯ïŒÃ3ãã«æžå°ã
ããèšåºåçã¯äžå€ã§ãã€ãã æ¬çºæã®è¬åãçšããæ²»çãã¬ãŒã¶ãŒè£ 眮ãçš
ããä»äºã§çºçããæç¹é åã®ã¬ãŒã¶ãŒèªçºçç
ãæããïŒäººã®æ£è ïŒïŒåã®ç®ïŒã«æœãããçç
ã®çŒåºé åã¯ç¶²èåºè¡åã³æèŠäžç®ããããæµ®è «
ã§ç¹åŸŽä»ãããããïŒã€ã®çäŸã®å Žåã«èŠåã¯
0.3ã«èœã¡ãŠãããããïŒã€ã®çäŸã¯0.1ã0.2ã«èœ
ã¡ãŠãããèŠéã¯ïŒÃ10ãã®çµ¶å¯Ÿæç¹ãæããŠã
ããæ¬çºæã®è¬åãçšããæ²»çåŸïŒã€ã®ç®ã®èŠå
ã¯1.0ã«æ»ããåºè¡åã³æµ®è «ã¯å®å šã«è§£æ±ºããã
ãããã®ç®ã®ïŒã€ïŒåºè¡åã³æµ®è «ã®çŠç¹ãå¹³åç€
ç¶çµç¹ã®äžé åãå ãã倧é åã®çœ¹æ£ãåããã
ã®ïŒã«ãããŠã¯ãèŠåã¯åããŸãã«æ®ããåâ網
èåºè¡ã¯å®å šã«åžåãããå·è·¡ã«é¡äŒŒããæ¿ãç
è²é åãäžå¿çŒåºã«åœ¢æãããã ãã®ããã«ãæ¬çºæã®è¬åã¯ãæ²»ççµäºåã«80
ïŒ ã®å®å šå¿ççãæããŠãã¬ãŒã¶ãŒåã³å€ªéœèªçº
網èççã®æ²»çã«æçšãªæ¥µããŠåŒ·åãªæ²»çå¹æã
æãããã®ã§ããããã®ä»ã®æ²»çæ§åŒã䜿çšãã
ãå Žåã«ã¯ãã¬ãŒã¶ãŒèªçºç¶²èççã®15ã30ïŒ ã§
å®å šãªèŠåãåååŸãããããã¯æ²»çã®éå§åŸ
1.5ãïŒã±æåŸã«èŠããããäžèšããæ¬çºæã®è¬
åã¯åçš®ç å ã®ç¶²èç«å·ã®æ²»çã«æ¥µããŠæçã§ã
ããšçµè«ããããšãã§ããã æ¬çºæã®è¬åã¯ã¹ãã¬ã¹ãæ¿ããå ãé«é žçŽ
çãçŒçå åºè¡ã«ããããã網èã«å¯ŸããŠæçãª
äœçšãåãŒã網èä¿è·å€ã§ããããã®çµæç©ã®èš
åºçåã³å®éšçç 究ã§ã¯æ¬çºæã®è¬åã«ã¯çŒå åº
è¡ã®è¿ éãªåžåã滲åºæŽ»æ§é»æ¢ãæèŠäžç®å¥é¢ã
ãã³è質æ²ç©ã®çšåºŠã®æžå°ãèŠåæ©èœã®å埩ãä¿
é²ããåºç¯ãªç¹æ§ãæãããã®ã§ããããšã瀺ã
ããããã®è¬åã®äœçšæ©æ§ã®ç 究ããã®ããŒã¿ã®
è©äŸ¡ã§ã¯ãããã¯ãã¢ã°ããã³ã«ããèªçºããã
èè³ªé žåã«é»æ¢ç圱é¿ãåãŒããè¡çïŒèµ€è¡çïŒ
ã®èæ§é ãå¢åŒ·ããè¡æ¶²åœ¢ææåïŒè¡å°æ¿ïŒã®å
éãæå¶ãããã€ããªã³ã¢ãããŒãããã€ããªã³
ããªããŒãžã®è»¢æé床ãé ããïŒæéåå¹æïŒã
è¡æ¶²ã®ãã€ããªã³æº¶è§£æŽ»æ§ãé«ããè¡æ¶²ã®ã¬ãªã
ãžãŒç¹æ§ãåºæ¿ããçŒå åºè¡ã«ãããè¡ç®¡äœåæ§
äœçšãåãŒããåã³ç°ç¶ãã¯ã¬ãªããé¡ã®ãã¹ã
ãžãšã¹ãã©ãŒãŒãšæå¹ã«ç«¶äºãããšããããšã瀺
ããŠããã æ¬çºæã®è¬åã«ãã瀺ãããåºãç¯å²ã®æ²»çäœ
çšã¯åçš®ç å ã®çŒå åºè¡ãè絡網èåã³å 倩æ§ãž
ã¹ãããã€ãŒã網èç«å·ãåã³ã¬ãŒã¶ãŒååºã«ã
ããæå·é²æ¢ã«é©çšå¯èœã§ããã æ¬çºæã®è¬åã®æŽ»æ§ç©è³ªã¯ãå®è³ªçã«åŸ®çŽ°çµæ¶
çœè²ç¡èç²æ«ã§ãããå³ã¯å ãã«é žã€ã±ããæ°Žå
ã³ã¢ã«ã³ãŒã«ã«æ溶æ§ã§ããããšãŒãã«åã³ã¢ã»
ãã³ã«è²§æº¶æ§ã§ãããé«æž©ïŒ200âãŸã§ïŒã«å®å®
ã§ããã æ¬çºæã®è¬åã¯ãåžžæ³ã«ããå皮治ç圢æ ïŒäŸ
ãã°ãçŒç¹æ»Žã泚å°æ¶²ãé å€ïŒã§èª¿è£œããããšã
ã§ããã奜ãŸããã¯ãæ¬çºæã®è¬åã¯ãçµèäžæ
ãã¯çŒçåŸæ¹æ³šå°æ¶²ã®åœ¢æ ã§äœ¿çšããã®ã奜ãŸã
ããæ²»çç®çã®ããã«ãæ¬çºæã®è¬åã¯çµèäžæ
äžã«ããïŒïŒ 溶液ã®0.3mlæäžéã§æ¯æ¥ïŒå10ã
15æ¥éæãã¯åçŒçåŸæ¹æ²»çã«ããïŒïŒ 溶液ã®
0.5mlæäžéã§æ¯æ¥ïŒå10ã15æ¥éæäžãããã ã¬ãŒã¶ãŒååºã«ãããå¯å¹²æžæ§ç §å°ã®æ害ãªå¹
æãã網èãå®ãããã«ãæ¬çºæã®è¬åã¯ã¬ãŒã¶
ãŒååºã®ïŒæ¥åã«ïŒïŒ 溶液ã®0.5mlæäžéã§çŒç
åŸæ¹ã§å°å ¥ããã次ãã§åŠçã®ïŒæéåã«ããè¿
ããããåŒç¶ãåŠæ¹ãšããŠã¯ããã®è¬åããåäž
æäžéïŒïŒïŒ 溶液0.5mlïŒã§æ¯æ¥ïŒåçšããããŠ
çŒçåŸæ¹æ³šå°ã«ããïŒãïŒæ¥éäžããããã æ¬çºæã®è¬åã®æ²»çã«ã¯äœçã®å¯äœçšåã³çŠå¿
ã¯ååšããªããæ¬çºæã®è¬åã¯å ããä¿è·ããã
å Žæã«è²¯èµãããã¹ãã§ããã
ã¯ã22ã®ç®ã®ãã¡20ã«ãããèŠåã®å¢å€§åã³æ²»ç
ã«æ®éæµæããâæã®ç æ°ã®20ã®ç®ã®ãã¡13
ã®ç®ã«ãããäžå¿æç¹ã®æžå°ã§ãã€ããã¹ã¿ãŒã
ã«ãç ã«ãããŠæ¬çºæã®è¬åãçšããåŠæ¹ã«ãã
æ²»çå¹æã®è©äŸ¡ãå ¬ç¥ã®è©Šè¬ãã©ãããŒã
ïŒflavinatïŒãšå¯Ÿæ¯ããŠæ€èšãããšãããåè ã®
æ¹ãããåªããŠããããšã瀺ãããã æ¬çºæã®è¬åãçšããæ²»çïŒïŒïŒ è¬å溶液ã
0.5mlæäžéã§çŒçåŸæ¹ããæäžãããNo.15ïŒãã
ä¿è·çŒé¡ãªãã§æ¥èã芳å¯ããçµææç¹é åã®å€ª
éœèªçºççãæããïŒäººã®æ£è ïŒïŒåã®ç®ïŒã«ã
ããŠéå§ãããæ£è ã¯16ã35æã§ãããå·ã®éå§
ããïŒãïŒã±æçµãŠãããå§èšç §äŒã«ãããäžå¹³
ã«ã¯ãèŠåãäœäžããããšåã³ãããããç®ã«ã
ãã10Ã10ãã®äžå¿æç¹ããã€ããèŠåã¯ïŒã€ã®
ç®ã«ãããŠã0.8ã«æžå°ããŠãããç 究æ£è ã®èŠ
éã¯äžå¿ã«äœçœ®ãã絶察æç¹ã瀺ãããæ¬çºæã®
è¬åãçšããæ²»çåŸãïŒã€ã®ç®ã®èŠåã¯0.8ãã
1.0ã«äžæããïŒã€ã®ç®ã¯0.5ãã0.6ã«äžæããã
å šãŠã®ç®ã«ãããŠçµ¶å¯Ÿæç¹é åã¯ïŒÃ3ãã«æžå°ã
ããèšåºåçã¯äžå€ã§ãã€ãã æ¬çºæã®è¬åãçšããæ²»çãã¬ãŒã¶ãŒè£ 眮ãçš
ããä»äºã§çºçããæç¹é åã®ã¬ãŒã¶ãŒèªçºçç
ãæããïŒäººã®æ£è ïŒïŒåã®ç®ïŒã«æœãããçç
ã®çŒåºé åã¯ç¶²èåºè¡åã³æèŠäžç®ããããæµ®è «
ã§ç¹åŸŽä»ãããããïŒã€ã®çäŸã®å Žåã«èŠåã¯
0.3ã«èœã¡ãŠãããããïŒã€ã®çäŸã¯0.1ã0.2ã«èœ
ã¡ãŠãããèŠéã¯ïŒÃ10ãã®çµ¶å¯Ÿæç¹ãæããŠã
ããæ¬çºæã®è¬åãçšããæ²»çåŸïŒã€ã®ç®ã®èŠå
ã¯1.0ã«æ»ããåºè¡åã³æµ®è «ã¯å®å šã«è§£æ±ºããã
ãããã®ç®ã®ïŒã€ïŒåºè¡åã³æµ®è «ã®çŠç¹ãå¹³åç€
ç¶çµç¹ã®äžé åãå ãã倧é åã®çœ¹æ£ãåããã
ã®ïŒã«ãããŠã¯ãèŠåã¯åããŸãã«æ®ããåâ網
èåºè¡ã¯å®å šã«åžåãããå·è·¡ã«é¡äŒŒããæ¿ãç
è²é åãäžå¿çŒåºã«åœ¢æãããã ãã®ããã«ãæ¬çºæã®è¬åã¯ãæ²»ççµäºåã«80
ïŒ ã®å®å šå¿ççãæããŠãã¬ãŒã¶ãŒåã³å€ªéœèªçº
網èççã®æ²»çã«æçšãªæ¥µããŠåŒ·åãªæ²»çå¹æã
æãããã®ã§ããããã®ä»ã®æ²»çæ§åŒã䜿çšãã
ãå Žåã«ã¯ãã¬ãŒã¶ãŒèªçºç¶²èççã®15ã30ïŒ ã§
å®å šãªèŠåãåååŸãããããã¯æ²»çã®éå§åŸ
1.5ãïŒã±æåŸã«èŠããããäžèšããæ¬çºæã®è¬
åã¯åçš®ç å ã®ç¶²èç«å·ã®æ²»çã«æ¥µããŠæçã§ã
ããšçµè«ããããšãã§ããã æ¬çºæã®è¬åã¯ã¹ãã¬ã¹ãæ¿ããå ãé«é žçŽ
çãçŒçå åºè¡ã«ããããã網èã«å¯ŸããŠæçãª
äœçšãåãŒã網èä¿è·å€ã§ããããã®çµæç©ã®èš
åºçåã³å®éšçç 究ã§ã¯æ¬çºæã®è¬åã«ã¯çŒå åº
è¡ã®è¿ éãªåžåã滲åºæŽ»æ§é»æ¢ãæèŠäžç®å¥é¢ã
ãã³è質æ²ç©ã®çšåºŠã®æžå°ãèŠåæ©èœã®å埩ãä¿
é²ããåºç¯ãªç¹æ§ãæãããã®ã§ããããšã瀺ã
ããããã®è¬åã®äœçšæ©æ§ã®ç 究ããã®ããŒã¿ã®
è©äŸ¡ã§ã¯ãããã¯ãã¢ã°ããã³ã«ããèªçºããã
èè³ªé žåã«é»æ¢ç圱é¿ãåãŒããè¡çïŒèµ€è¡çïŒ
ã®èæ§é ãå¢åŒ·ããè¡æ¶²åœ¢ææåïŒè¡å°æ¿ïŒã®å
éãæå¶ãããã€ããªã³ã¢ãããŒãããã€ããªã³
ããªããŒãžã®è»¢æé床ãé ããïŒæéåå¹æïŒã
è¡æ¶²ã®ãã€ããªã³æº¶è§£æŽ»æ§ãé«ããè¡æ¶²ã®ã¬ãªã
ãžãŒç¹æ§ãåºæ¿ããçŒå åºè¡ã«ãããè¡ç®¡äœåæ§
äœçšãåãŒããåã³ç°ç¶ãã¯ã¬ãªããé¡ã®ãã¹ã
ãžãšã¹ãã©ãŒãŒãšæå¹ã«ç«¶äºãããšããããšã瀺
ããŠããã æ¬çºæã®è¬åã«ãã瀺ãããåºãç¯å²ã®æ²»çäœ
çšã¯åçš®ç å ã®çŒå åºè¡ãè絡網èåã³å 倩æ§ãž
ã¹ãããã€ãŒã網èç«å·ãåã³ã¬ãŒã¶ãŒååºã«ã
ããæå·é²æ¢ã«é©çšå¯èœã§ããã æ¬çºæã®è¬åã®æŽ»æ§ç©è³ªã¯ãå®è³ªçã«åŸ®çŽ°çµæ¶
çœè²ç¡èç²æ«ã§ãããå³ã¯å ãã«é žã€ã±ããæ°Žå
ã³ã¢ã«ã³ãŒã«ã«æ溶æ§ã§ããããšãŒãã«åã³ã¢ã»
ãã³ã«è²§æº¶æ§ã§ãããé«æž©ïŒ200âãŸã§ïŒã«å®å®
ã§ããã æ¬çºæã®è¬åã¯ãåžžæ³ã«ããå皮治ç圢æ ïŒäŸ
ãã°ãçŒç¹æ»Žã泚å°æ¶²ãé å€ïŒã§èª¿è£œããããšã
ã§ããã奜ãŸããã¯ãæ¬çºæã®è¬åã¯ãçµèäžæ
ãã¯çŒçåŸæ¹æ³šå°æ¶²ã®åœ¢æ ã§äœ¿çšããã®ã奜ãŸã
ããæ²»çç®çã®ããã«ãæ¬çºæã®è¬åã¯çµèäžæ
äžã«ããïŒïŒ 溶液ã®0.3mlæäžéã§æ¯æ¥ïŒå10ã
15æ¥éæãã¯åçŒçåŸæ¹æ²»çã«ããïŒïŒ 溶液ã®
0.5mlæäžéã§æ¯æ¥ïŒå10ã15æ¥éæäžãããã ã¬ãŒã¶ãŒååºã«ãããå¯å¹²æžæ§ç §å°ã®æ害ãªå¹
æãã網èãå®ãããã«ãæ¬çºæã®è¬åã¯ã¬ãŒã¶
ãŒååºã®ïŒæ¥åã«ïŒïŒ 溶液ã®0.5mlæäžéã§çŒç
åŸæ¹ã§å°å ¥ããã次ãã§åŠçã®ïŒæéåã«ããè¿
ããããåŒç¶ãåŠæ¹ãšããŠã¯ããã®è¬åããåäž
æäžéïŒïŒïŒ 溶液0.5mlïŒã§æ¯æ¥ïŒåçšããããŠ
çŒçåŸæ¹æ³šå°ã«ããïŒãïŒæ¥éäžããããã æ¬çºæã®è¬åã®æ²»çã«ã¯äœçã®å¯äœçšåã³çŠå¿
ã¯ååšããªããæ¬çºæã®è¬åã¯å ããä¿è·ããã
å Žæã«è²¯èµãããã¹ãã§ããã
第ïŒå³ã第ïŒå³åã³ç¬¬ïŒå³ã¯ç¶²èé»äœå³ã瀺
ãã第ïŒå³ïŒ¡ïŒïŒ¢ã¯èšé²ãããå åºæã瀺ãã°ã©
ãã§ããã第ïŒå³åã³ç¬¬ïŒå³ã¯ããŒã©ãã°ã©ã ã
瀺ãã
ãã第ïŒå³ïŒ¡ïŒïŒ¢ã¯èšé²ãããå åºæã瀺ãã°ã©
ãã§ããã第ïŒå³åã³ç¬¬ïŒå³ã¯ããŒã©ãã°ã©ã ã
瀺ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ ãæãã掻æ§ç©è³ªïŒâãšãã«âïŒâã¡ãã«âïŒâ
ããããã·ãããªãžã³å¡©é žå¡©åã³è¬åŠççšéå€ã
å«ãã§ãªãããšãç¹åŸŽãšããçŒå åºè¡ãè¿èŠæ§è
絡網èãžã¹ãããã€ãŒãå 倩æ§ç¶²èãžã¹ãããã€
ãŒã網èç«å·ã®æ²»ççšåã³ã¬ãŒã¶ãŒååºã«ããã
æå·é²æ¢çšç¶²èä¿è·å€ã ïŒ ïŒééïŒ ã®æŽ»æ§ç©è³ªãå«æãã泚å°æ¶²åœ¢æ ã§
ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç¶²èä¿è·å€ã ïŒ è©²è¬åŠççšéå€ãèžçæ°Žã§ãããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé èšèŒã®ç¶²èä¿è·å€ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/523,954 US4486440A (en) | 1983-08-17 | 1983-08-17 | Retinoprotector for treating intraocular hemorrhage, myopic, chorioretinal dystrophies, congenital retinal dystrophies, retinal burns and prevention of injury in lasercoagulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6061526A JPS6061526A (ja) | 1985-04-09 |
| JPH0129167B2 true JPH0129167B2 (ja) | 1989-06-08 |
Family
ID=24087103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58171064A Granted JPS6061526A (ja) | 1983-08-17 | 1983-09-16 | çŒå åºè¡ïŒè¿èŠæ§è絡網èãžã¹ãããã€âïŒå 倩æ§ç¶²èãžã¹ãããã€âïŒç¶²èç«å·ã®æ²»ççšåã³ã¬âã¶âååºã«ãããæå·é²æ¢çšç¶²èä¿è·å€ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4486440A (ja) |
| JP (1) | JPS6061526A (ja) |
| CH (1) | CH658595A5 (ja) |
| DE (1) | DE3330053A1 (ja) |
| FR (1) | FR2551659B1 (ja) |
| SE (1) | SE8304616L (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008102A (en) * | 1986-02-26 | 1991-04-16 | York Kenneth K | Biocompatible intraocular light-screening compositions and methods of intraocular light screening |
| US6161770A (en) | 1994-06-06 | 2000-12-19 | Sturman; Oded E. | Hydraulically driven springless fuel injector |
| JP3688339B2 (ja) * | 1995-02-28 | 2005-08-24 | æ ªåŒäŒç€Ÿããã㯠| ã¬âã¶æ²»çè£ çœ® |
| DE19718826A1 (de) * | 1997-05-05 | 1998-11-12 | Marion S Dr Eckmiller | Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des ExtrazellulÀr-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung |
| US6085991A (en) | 1998-05-14 | 2000-07-11 | Sturman; Oded E. | Intensified fuel injector having a lateral drain passage |
| RU2362554C2 (ru) * | 2007-09-27 | 2009-07-27 | ÐкаÑеÑОМа ÐалеМÑОМПвМа ÐПпаÑОМа | РегеМеÑОÑÑÑÑее пÑПÑОвПвПÑпалОÑелÑМПе ÑÑеЎÑÑвП О ÑпПÑÐŸÐ±Ñ Ð»ÐµÑÐµÐœÐžÑ Ñ Ð¿ÐŸÐŒÐŸÑÑÑ ÑÑПгП ÑÑеЎÑÑва |
| TR200904159A1 (tr) | 2009-04-17 | 2010-11-22 | Sanovel Ä°laç San. Ve TiÌc. A.Å. | DeÄiÅtirilmiÅ salım saÄlayan emoksipin formÃŒlasyonları. |
| CN101891677B (zh) * | 2010-07-13 | 2012-07-25 | ç»å ŽæçåŠé¢ | 6-ç²åº-2-ä¹åº-3-çŸåºå¡å¶çç产æ¹æ³ |
| US9614209B2 (en) * | 2013-02-25 | 2017-04-04 | The Boeing Company | Aircraft including mitigation system for rechargeable batteries |
| RU2605825C1 (ru) * | 2015-12-01 | 2016-12-27 | ÐОÑалОй ÐÐŽÑаÑÐŽÐŸÐ²ÐžÑ ÐПÑПвОкПв | РаÑÑÐ²ÐŸÑ ÐŽÐ»Ñ Ð²ÐœÑÑÑОвеММПгП О вМÑÑÑОЌÑÑеÑМПгП Ð²Ð²ÐµÐŽÐµÐœÐžÑ ÐœÐ° ПÑМПве ÑÑОлЌеÑОлгОЎÑПкÑОпОÑОЎОМа ÑÑкÑОМаÑа О ÑпПÑПб егП пПлÑÑÐµÐœÐžÑ |
| RU2652891C1 (ru) * | 2017-03-16 | 2018-05-03 | ÐМЎÑей ÐÐžÐºÐŸÐ»Ð°ÐµÐ²ÐžÑ ÐПлЎÑÑев | СалОÑÐžÐ»Ð°Ñ 2-ÑÑОл-6-ЌеÑОл-3-гОЎÑПкÑОпОÑОЎОМа, егП ÑПлÑваÑÑ Ðž гОЎÑаÑÑ Ðž ÑпПÑÐŸÐ±Ñ ÐžÑ Ð¿ÐŸÐ»ÑÑÐµÐœÐžÑ |
| RU2663836C1 (ru) * | 2017-12-14 | 2018-08-10 | ÐкÑОПМеÑМПе ПбÑеÑÑвП "ÐÐ°ÐŽÐŒÐžÑ ÑÑейЎ" | L-ÐМаМÑÐžÐŸÐŒÐµÑ 2-ÑÑОл-6-ЌеÑОл-3-гОЎÑПкÑОпОÑÐžÐŽÐžÐœÐžÑ Ð³ÐžÐŽÑПкÑОбÑÑаМЎОПаÑа, ПблаЎаÑÑОй ÑеÑебÑПпÑПÑекÑПÑМПй акÑОвМПÑÑÑÑ |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3983238A (en) * | 1972-10-20 | 1976-09-28 | Sankyo Company Limited | Substituted pyridinol-containing compositions and methods for the treatment of coccidiosis |
-
1983
- 1983-08-16 CH CH4452/83A patent/CH658595A5/de not_active IP Right Cessation
- 1983-08-17 US US06/523,954 patent/US4486440A/en not_active Expired - Fee Related
- 1983-08-19 DE DE3330053A patent/DE3330053A1/de active Granted
- 1983-08-25 SE SE8304616A patent/SE8304616L/xx unknown
- 1983-09-08 FR FR8314339A patent/FR2551659B1/fr not_active Expired
- 1983-09-16 JP JP58171064A patent/JPS6061526A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE3330053A1 (de) | 1985-02-28 |
| FR2551659B1 (fr) | 1986-07-04 |
| DE3330053C2 (ja) | 1988-12-08 |
| CH658595A5 (de) | 1986-11-28 |
| JPS6061526A (ja) | 1985-04-09 |
| US4486440A (en) | 1984-12-04 |
| SE8304616L (sv) | 1985-02-26 |
| SE8304616D0 (sv) | 1983-08-25 |
| FR2551659A1 (fr) | 1985-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4198988B2 (ja) | çŒã®è¡ç®¡æ°çããã³ç¥çµå·å®³ãåŠçœ®ããããã®æ¹æ³ããã³çµæç© | |
| Callahan | Prevention of blindness after blepharoplasty | |
| Deutsch et al. | Indications for surgical management of hyphema in patients with sickle cell trait | |
| JPH0129167B2 (ja) | ||
| Kitazawa et al. | Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd: YAG laser iridotomy | |
| Corbett et al. | Intraocular adrenaline maintains mydriasis during cataract surgery. | |
| TW200305398A (en) | Use of ROM production and release inhibitors to treat and prevent intraocular damage | |
| WO1999004772A2 (en) | Use of levobupivacaine | |
| US5212168A (en) | Method of and solution for treating glaucoma | |
| US4904649A (en) | Method and solution for treating glaucoma | |
| Galin et al. | Levobunolol vs timolol for open-angle glaucoma and ocular hypertension | |
| Rosenlund | The intraocular pressure lowering effect of timolol in gelâforming solution | |
| Wiles et al. | Control of intraocular pressure with apraclonidine hydrochloride after cataract extraction | |
| Araie et al. | Effects of apraclonidine on intraocular pressure and blood-aqueous barrier permeability after phacoemulsification and intraocular lens implantation | |
| Kjellgren et al. | The shortâtime effect of latanoprost on the intraocular pressure in normal pressure glaucoma | |
| Lewis et al. | Subacute angleâclosure glaucoma as a cause of headache in the presence of a white eye | |
| Kramer | Epinephrine distribution after topical administration to phakic and aphakic eyes. | |
| Boozman et al. | Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure | |
| Hill et al. | Apraclonidine prophylaxis for postcycloplegic intraocular pressure spikes | |
| Karkhaneh et al. | Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema | |
| RU2198641C2 (ru) | СпПÑПб леÑÐµÐœÐžÑ Ð³Ð»Ð°Ð·ÐœÑÑ Ð±ÐŸÐ»ÐµÐ·ÐœÐµÐ¹ | |
| RU2303449C1 (ru) | СпПÑПб леÑÐµÐœÐžÑ ÐŸÑеÑМПй ÑПÑÐŒÑ ÐŽÐžÐ°Ð±ÐµÑОÑеÑкПй ЌакÑлПÑеÑОМПпаÑОО | |
| Moore | 8 Chapter Anticholinergic Agents (Parasympatholytics) | |
| JP3530542B2 (ja) | çŒç§çšã¢ã«ã¬ãããã³è£œå€ | |
| RU2290191C2 (ru) | СпПÑПб леÑÐµÐœÐžÑ ÑÑбеÑкÑлезМÑÑ ÑвеОÑПв |